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Abstract: Infectious diarrhea is an important public health problem and a major cause of 
morbidity all over the world. Infants and young children are the most vulnerable group. 
Vaccination is one of the most important public health tools for the prevention of 
infectious diseases, however, formulation of safe and effective vaccines against diarrheal 
disease can be challenging. Shigella, Salmonella and Yersinia enterocolitica are three 
highly virulent pathogens in urgent need of vaccine development. A common virulence 
factor is utilized by these three pathogens, the type III secretion system (T3SS), which is 
highly conserved across multiple serotypes within these groups. With the discovery that 
the Shigella T3SS proteins IpaD and IpaB are protective antigens, we constructed a novel 
IpaD-IpaB fusion protein to simplify the production and reduce the cost of vaccine 
production. Because of its hydrophobic IpaB portion, the DB fusion needs detergent to 
maintain solubility. A mild detergent called LDAO was identified and showed great 
promise for protein stabilization when compared to the detergent used previously (called 
OPOE). Inspired by the success of the DB fusion, we constructed a SipDB fusion using 
the homologous Salmonella T3SS proteins SipD and SipB. In addition to exploring the 
fusion strategy with regard to anti-Shigella and anti-Salmonella vaccines, a relatively new 
antigen delivery system called Bacterium-Like Particles (BLPs) was also explored and 
formulated as a potential means for delivering protective antigens from Shigella, 
Salmonella and Yersinia enterocolitica (LcrV and YopB). Derived from Lactococcus 
lactis, BLPs are peptidoglycan skeletons that are safe for newborns and can carry 
multiple antigens on their surface. The T3SS proteins were fused with a protein anchor 
domain for BLP attachment. The constructed fusion vaccine candidates and BLP-based 
vaccine candidates were biophysically characterized using multiple techniques including 
circular dichroism spectroscopy, intrinsic fluorescence spectroscopy, and static light 
scattering which allowed measuring the secondary, tertiary and quaternary structural 
changes, respectively, as a function of environmental stress. The resulting large dataset 
was summarized using a three-index empirical phase diagram (EPD), which is a colored 
representation of the overall structural integrity and conformational stability of the 
vaccine candidates in response to environmental conditions. The information acquired is 
used for identifying favorable states of protein and the proper detergent to be used for the 
formulation of the resulting vaccines. This approach can also be used in further studies on 
excipient screening for stabilizing final vaccine products, though that work was not done 
here.  
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CHAPTER I 
 
LITERATURE REVIEW 
 
Historical Overview of Shigella 
Shigella spp. are gram-negative, nonmotile, rod-shaped, facultative intracellular bacteria 
belonging to the family Enterobacteriaceae.   Shigella was first discovered as the bacterial cause 
of bacillary dysentery by Dr. Kiyoshi Shiga in 1897 [1]. Over the next several years, a number of 
Shigella strains were identified and grouped into four species – Shigella  flexneri, S. sonnei, 
S.dysenteriae and S. boydii [2]. Among these four species, S. flexneri and S. sonnei are 
responsible for the majority of reported Shigella infections[3].  Meanwhile, S.dysenteriae causes 
the most severe form of dysentery (and can lead to hemorrhagic colitis and hemolytic uremic 
syndrome) and contributes the majority of mortality[4]. All four species typically lead to 
shigellosis, an important gastrointestinal disease characterized by fever, diarrhea containing blood 
and mucous, and abdominal cramping. Although shigellosis is mostly self-limiting, it can be life-
threatening, especially for children under 5 years of age.  In 2009, WHO reported approximately 
90 million cases of shigellosis leading to about 100 thousand deaths annually [5]. Shigella spp. 
are transmitted through the fecal-oral route, which is why most of these infections occur in 
developing countries where there are poor sanitary conditions and contaminated water supplies. 
Children are especially impacted by shigellosis and in the developing world repeated episodes 
often increase the developmental problems already caused by malnutrition and can lead to stunted 
growth and impaired cognitive development. 
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Cellular Pathogenesis of Shigella 
Shigella have a limited host range and essentially only infect humans.  After ingestion, 
the pathogen is able to survive the acidic environment of the stomach and passes through the 
small intestine [6]. Like some other pathogens, Shigella can down-regulate the host expression of 
antimicrobial peptides (AMPs) produced by phagocytes and the cells at epithelial surfaces, which 
enhances pathogen survival [7,8]. Instead of invading colonic epithelial cells from their apical 
side, Shigella exits the lumen of the large intestine by transcytosis across microfold cells (M 
cells) which are continuously sampling the contents of the gut lumen for presentation of potential 
invaders to underlying phagocytic and lymphoid cells [9,10]. After transcytosis, the bacteria 
encounter resident macrophages and are quickly engulfed. Shigella then rapidly induces apoptosis 
(pyroptosis) of these macrophages to ultimately facilitate bacterial access to the basal side of the 
colonic epithelium [11,12]. In this process, the dying macrophages have their caspase 1 activated 
which leads to the release of the proinflammatory cytokine interleukin-1β along with the release 
of IL-18.  This triggers infiltration of polymorphonuclear leukocytes (i.e. PMNs or neutrophils) to 
the infection site and the stimulation of natural killer (NK) cells to produce and release IFN-
γ[13,14]. After inducing macrophage cell death, the Shigella escape from the apoptotic 
macrophages which provides them access to the basal side of the overlying epithelium. The 
Shigella are able to invade the epithelial cells from this position by altering normal host cells 
functions using a bacterial type III secretion system (T3SS). The T3SS consists of a “needle and 
syringe” that allows the Shigella to inject effector proteins into host cells which leads to cell 
membrane ruffling and incorporation of the bacterium into a spacious phagosome [15]. Once 
inside the host cell, Shigella dissolves the vacuolar membrane to gain access to the host cell 
cytoplasm where it then replicates. While in the host cytoplasm, Shigella recruits host cell actin to 
allow it to move about the cytoplasm by a process called actin-based motility (ABM). ABM then 
allows the bacteria to push outward against the host membrane to enter a neighboring cell.  The 
protrusion into the second cell then pinches off and the double membrane-bound vacuole is lysed. 
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In this process called intercellular spread. Shigella is able to spread while avoiding the 
extracellular environment and the host immune system [16]. 
 
Type III Secretion System 
Type III secretion systems (T3SS) are needle-like molecular nanomachines that can be 
found in numerous plant and animal bacterial pathogens including Salmonella spp., Yersinia spp., 
Enteropathogenic and Enterohemorrhagic   Escherichia  coli (EPEC and EHEC, respectively), 
Pseudomonas spp. and Shigella spp. Salmonella enterica serovars Typhimurium and Typhi even 
possesses two T3SSs (encoded by the Salmonella pathogenicity islands SPI1 and SPI2) which 
accommodate invasion of target epithelial cells and subsequent adaptation to an intracellular 
lifestyle, respectively. These pathogens cause various types of diseases and have very different 
infection strategies.  For example, Shigella and Salmonella are intracellular pathogens while 
Yersinia, EHEC and EPEC are extracellular pathogens. For all of these pathogens, however, the 
T3SS is an essential virulence factor that has a central role in pathogenesis.  
Despite the range of infections caused by bacteria that possess T3SSs, the type III 
secretion apparatus (T3SA) found in all these pathogens share many structural features. The first 
injectisome or T3SA needle complex that was visualized by electron microscopy was from S. 
typhimurium [17], however, the S. flexneri T3SS is closely related to this one at the structural and 
protein sequence level and is also well studied. Therefore, the following discussion will focus on 
the Shigella T3SS/T3SA which is encoded on a large virulence factor by the ipa (invasion 
plasmid antigen), spa (surface-presentation of antigens) and mxi (major exporter of Ipa proteins) 
genetic loci. The T3SA structurally consists of a basal body, an external needle and a needle tip 
complex. The basal body spans the inner and outer membranes of the bacterium and supports the 
entire complex structure. An ATPase located on the cytoplasmic side of the basal body energizes 
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the system for the transport of effector proteins. The T3SA needle is composed of multiple copies 
of a protein called MxiH arranged helically and protruding from the basal body to the cell surface 
beyond the outer membrane LPS layer. The needle contains a channel that allows partially 
unfolded proteins to pass through when activated. The needle tip complex lies at the distal end of 
the T3SA needle and in its most mature form it is composed of multiple copies of a tip protein 
and two translocon proteins. In the case of Shigella, the three proteins would be IpaD (the needle 
tip protein), IpaB (the first hydrophobic translocator protein) and IpaC (the final hydrophobic 
translocator protein). Homologs of these and many other T3SA proteins can be found in other 
pathogens possessing T3SSs (see Table 1).  The tip complex is able to respond to extracellular 
signals to control the secretion of effector proteins by first forming a translocon pore onto the host 
cell membrane and then allowing the passage of effector proteins through the pore and into the 
target cell cytoplasm [4,18,19,20]. 
 
Development of a Vaccine Against Shigella 
Shigellosis continues to be an important cause of morbidity and mortality all over the 
world and great efforts have been made toward the development of a Shigella vaccine, especially 
one that targets children in the developing world. Unfortunately, there is still no approved vaccine 
available, due in part to the many obstacles impeding the development of a broadly protective 
Shigella vaccine. These obstacles include the lack of good animal models, the need to overcome 
the many Shigella serotypes, and difficulties in large scale production. Different approaches have 
been explored and can be categorized into serotype-based vaccines and conserved protein antigen 
(serotype independent) vaccines [21,22].  
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Table 1.1 Structural proteins of the T3SS Needle Apparatus 
 
 
Structural homologues of T3SS needle apparatus proteins are listed here for each 
bacterial pathogen. The general role for each in the type III secretion system is listed at the left. 
This table is from [19]. 
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The genus Shigella is divided into four species and further includes 43 serotypes 
according to variations in their lipopolysaccharide (LPS) O antigen composition. Fifteen 
serotypes are defined for S. dysenteriae, 8 for S. flexneri, 19 for S. boydii, while only one for S. 
sonnei. Serotype diversity brings many difficulties into the process of vaccine development. 
Serotype-based Shigella vaccines can be further classified as LPS-protein conjugate vaccines, 
live-attenuated vaccine strains, and killed whole-cell formulations. Several conjugate vaccines 
have been formulated with perhaps the most effective ones consisting of recombinant 
Pseudomonas aeruginosa exoprotein A(rEPA) conjugated with S. flexneri 2a LPS [23] and S. 
sonnei LPS (developed by National Institute of Child Health and Human Development), however, 
these vaccines cannot prime and protect immunologically naïve young children under 2 years of 
age [24,25]. Another serotype-based strategy is orally administered, live-attenuated or killed 
whole-cell vaccines. A few live attenuated vaccine candidates have been evaluated in human 
clinical trials and some positive results have been observed for adults [26,27]. Unfortunately, 
these live attenuated vaccines are only effective against the serotypes from which they are derived 
and so are not broadly effective in protecting against multiple Shigella serotypes or species. 
The use of conserved protective antigens as vaccine candidates has also been explored. 
One strategy has been to use outer membrane proteins prepared from Shigella [28,29]. A 
technology called ‘generalized modules of membrane antigens’ (GMMA) was developed to 
genetically produce outer membrane particles containing multiple Shigella outer membrane 
proteins without LPS. The GMMA were tested in a mouse model where a 65-100% protection 
was observed, however, it continues to remain at the preclinical stage [30].  
Another strategy is to employ the Ipa proteins from the Shigella type III secretion system. 
The invasion plasmid antigens (Ipa proteins) were originally identified by the antibody responses 
seen in individuals convalescing from shigellosis [31,32]. These proteins have long been known 
to be highly immunogenic during Shigella infection, however, their resent identification as 
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surface proteins within the context of the T3SS has made them potential vaccine targets [33,34]. 
As discussed above, a T3SS is essential for the virulence of Shigella regardless of serotype and 
the T3SA and its components are highly conserved among all the Shigella. Investigators at Walter 
Reed Army Institute of Research initially formulated a Shigella invasion complex (Shigella 
Invaplex) which was composed of LPS and the highly conserved Ipa proteins (IpaB, IpaC and 
IpaD) and prepared from fully virulent bacteria for use as a somewhat well-defined vaccine.  The 
Invaplex was tested in healthy volunteers and proved to be immunogenic and relatively safe 
[35,36]. A related LPS-containing formulation generated using purified recombinant IpaD and 
IpaB with adjuvant was subsequently developed and shown to grant some degree of heterologous 
protection in a mouse model depending upon the type(s) of LPS used [37]. 
 More recently, IpaB and IpaD have been used in the presence of adjuvants and the 
absence of any LPS to provide a fully serotype-independent subunit vaccine that could be used to 
protect against shigellosis.  Analysis of these proteins within the context of vaccine formulation 
will be the topic of the remaining chapters in this dissertation.  
 
Biophysical Characterization of Proteins 
A lot of effort must be put into developing vaccine formulations so that they are effective, 
safe and ready to be stored and/or shipped without losing activity. Macromolecule-based or 
higher order macromolecular complex-based vaccine formulation has developed rapidly in the 
last 30 years [38]. The reason for this late development is that the issue of macromolecule 
stability is often a tremendous problem associated with the formulation, transportation and 
storage of macromolecules. Such issues are typically less problematic with traditional small-
molecule products. The integrity (and thus activity) of macromolecules (especially proteins) can 
be affected by their intrinsic instability and environmental changes such as temperature and pH 
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fluxes or excipient incompatibility [39]. Therefore, it’s very important to ensure the maintenance 
of product structural integrity and conformational stability during formulation, shipping and 
storage. This is especially true for pharmaceutical macromolecules to be used in developing 
nations where shipping infrastructure and storage facilities can vary dramatically.   
Traditional standard analytical methods like X-ray crystallography, nuclear magnetic 
resonance (NMR) and/or cryo-electron microscopy are able to obtain high-resolution structural 
information for proteins and their complexes. These are high-resolution and powerful techniques 
for assessing macromolecule structure and integrity, however, limiting conditions like 
crystallization or isotopic labeling make these approaches impractical for medium- to high-
throughput testing of macromolecular pharmaceutical agents [40]. A set of alternative biophysical 
techniques with lower resolution and which provide analysis of protein secondary, tertiary and 
quaternary states and is amenable to high-throughput analyses is needed.  Such techniques are 
available and while individually they provide limited information on a macromolecule, the 
combination could be, if used appropriately, applied to monitor the structural and conformational 
alterations of the macromolecules in response to different environmental conditions.  
One commonly used technique for protein analysis is far-UV Circular Dichroism (CD) 
spectroscopy, which is used to determine the content of a protein’s secondary structure and to 
monitor secondary structure changes. Secondary structure characteristics such as α-helical 
content, the presence of β sheets and the presence of turns or unfolded structure exhibit unique 
and quantifiable CD signals. For example, double minima at 208 and 222 nm and a prominent 
maximum at around 191 to 193 nm are strong indicators that a protein contains a dominant α-
helical structure. Meanwhile, β sheet structures typically exhibit a strong positive maximum 
between 195 and 200 nm and a single minimum between 215 and 217 nm [41]. In contrast, 
random coil (unstructured) peptides tend to show little signal above 200 nm and a minimum near 
195 nm.  In folded proteins, the CD spectrum is typically a mixture of all three secondary 
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structure types, but there are algorithms to help quantify overall secondary structure of a protein 
based on a reliable signal from about 190 nm to 240 nm. Most importantly, however, CD 
spectroscopy can be used to monitor minor secondary structure alterations in proteins as they are 
exposed to different solution conditions or environmental stresses such as high temperature which 
can led to protein unfolding [42]. 
In contrast to CD spectroscopy which measures signals from the polypeptide backbone of 
a protein, fluorescence spectroscopy can be used to monitor the microenvironments surrounding 
fluorescent aromatic amino acid side chains within a protein. Extrinsic fluorescent probes can 
also be used to reveal tertiary structure properties of a protein as will be discussed below.  
Intrinsic and extrinsic fluorescence spectroscopies are frequently used as simple low-resolution 
measures of protein tertiary structure changes. For proteins possessing tryptophan, intrinsic 
fluorescence spectroscopy is typically used to assess tertiary structure changes.  The indole side 
chain of Trp is a natural fluorophore with an absorbance near 290 nm and an emission spectrum 
that is highly sensitive to the polarity of the residue’s microenvironment. For example, the 
emission peak position of Trp UV fluorescence becomes a very useful probe of the structural 
change. Trp residues are typically buried within the apolar core of a fully folded protein. When 
they move into the more polar environment of the surrounding aqueous solvent due to unfolding 
of the protein, a red shift in peak position is usually observed. Interactions between the Trp and 
solutes or other amino acids can also influence the observed fluorescence emission [43]. 
Alternatively, Trp emission can be used to monitor tertiary structure changes in a protein since it 
tends to have greater emission when in apolar environments with decreased fluorescence upon 
movement into a polar environment such as would be seen in aqueous solutions.  The advantage 
of peak position over intensity, however, is that peak position can be monitored without influence 
from the concentration of the protein. 
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For proteins lacking Trp, an extrinsic fluorescence probe could be used that is very 
sensitive to the polarity of its microenvironment. One of the most widely used extrinsic dyes used 
for protein studies is 8-anilino-1-naphthalenesulfonate (ANS). ANS is nonfluorescent in aqueous 
solution, however, it is particularly attracted to the apolar regions of proteins where it binds to 
become highly fluorescent [44]. Thus, when a protein begins to unfold, apolar patches become 
accessible to the dye and this is observed as a dramatic increase in the fluorescence intensity of 
this extrinsic dye.   
In addition to secondary structure content and the tertiary structure (folding state) of a 
protein, the oligomeric status of a protein (quaternary structure) is important to consider when 
exploring its use as a potential vaccine.  Oligomerization can be a positive trait for proteins that 
naturally form discrete multimeric states, however, destabilization of a protein can often lead to 
aggregation which greatly compromises activity and potentially impairs use in a vaccine 
formulation.  Static light scattering (SLS) and dynamic light scattering (DLS) spectroscopies are 
techniques commonly used to characterize the quaternary structure and aggregation of a protein 
in solution. SLS analyzes the intensity of the scattered light and it is usually obtained 
simultaneously with fluorescence spectroscopy data by monitoring the light scattered at a 90° 
angle to the incident light at the excitation wavelength. SLS increases as the aggregative state of 
the protein increases. DLS measures the fluctuations in intensity of scattered light due to 
Brownian motion and it provides a more sensitive and quantifiable measure of protein 
aggregation or complex formation [38]. Thus, between CD spectroscopy, fluorescence 
spectroscopy and light scattering, it is possible to provide a comprehensive description of the 
secondary, tertiary and quaternary structure properties of a protein in a manner that is amenable to 
moderate- to high-throughput analysis. 
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Three-Index Empirical Phase Diagram (Three-Index EPDs) 
The techniques introduced above are practical methods for studying macromolecules to 
be used as biopharmaceutical agents.  There are also other techniques such as Fourier transform 
infrared (FTIR) spectroscopy, UV-visible absorption spectroscopy, near-UV CD spectroscopy 
that could also be used to investigate protein structure changes at the secondary and tertiary 
structure levels. Each of these techniques, however, focus on one specific aspect of protein 
structure and do not provide a picture of the overall structural transitions that occur in a protein in 
response to environmental changes. Thus, a high-throughput screening approach is needed that 
combines the various biophysical techniques used to monitor different structural characteristics of 
a macromolecule (e.g. protein) including secondary, tertiary and quaternary structures. The 
difficult point of such an analysis, however, is the interpretation of the large quantity of data 
generated from multiple biophysical analyses. An empirical phase diagram (EPD) was created by 
the research group of Dr. C. Russell Middaugh to successfully address this problem [45]. In the 
EPD, the datasets obtained from different techniques are combined to form an information-rich 
colorful map indicating the physical stability of the macromolecules or their complexes over a 
range of different conditions such as temperature, pH or ionic strength. Normally, two state 
conditions are picked to make a two phase space, for example, a temperature-pH phase space. 
Multiple-dimensional vectors representing the datasets obtained from a number of experimental 
techniques are then fit into the temperature-pH phase space. Each dataset consists of individual 
values against the temperature and pH, and is normalized to values between -1 and 1. Three 
datasets that contribute mostly are then picked and reduced to color based on an arbitrary 
red/green/blue (RGB) scheme using singular value decomposition (SVD) [38,45,46]. This 
approach has now been well developed and applied to numerous studies on the stabilization of 
protein therapeutics and vaccine formulations.  
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Although widely applied, EPDs as originally developed do have certain deficiencies. The 
most critical flaw is that the color transitions that appear in an EPD represent molecular structure 
changes, but as designed the color itself doesn’t mean anything specific with regard to these 
structural features. To overcome this flaw, a three-index EPD method has been recently 
developed. Far-UV CD spectroscopy, intrinsic fluorescence spectroscopy and static light 
scattering are applied to monitor the protein secondary, tertiary and quaternary structural changes, 
respectively. Meaningful colors are then specifically assigned to each dataset derived from an 
individual technique which means that there is a relationship between a specific color and a 
specific element of structure. In the research presented here, secondary structure has been 
assigned to red, tertiary structure has been assigned to green and aggregation state has been 
assigned to blue. A color map is thus constructed by summarizing the three color components and 
the resulting colors and the potential interpretation. Yellow color represents native state. Red, 
brown or pink usually represents variations of the molten globular state. Blue represents 
aggregation while black is indicative of an extensively unfolded state without aggregation [47]. 
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CHAPTER II 
 
MATERIALS AND METHODS 
 
Materials 
All the chemicals were purchased either from Sigma (St. Louis, MO) or Fisher Scientific 
(St. Louis, MO) with a small number of exceptions indicated in the text.   
 
Buffers and Reagents 
All the buffers, reagents and media recipes are listed in Appendix A and B respectively. 
 
Bacterial strains, media and growth conditions 
Escherichia coli strains containing plasmids are grown on Luria-Burtani (LB) agar plate 
or LB broth at 37 °C. For protein expression strains, two kinds of media are used, auto-
introduction media (AI) and terrific broth (TB).  Growth of liquid culture is under shaking at 200 
RPM. For auto-induction media, culture is grown at 37 °C all the time. For TB, bacteria are 
grown at 37 °C till OD reaches 1.0 and then moved to 17 °C and IPTG is added to 1 mM for 
induction. 
Antibiotic concentrations are 100 µg/ml ampicillin for pET15b, 34 µg/ml 
chloramphenicol for pACYC and 50 µg/ml kanamycin for pET28a.  
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Methods 
Generation of plasmids for expression of the IpaD-IpaB fusion genes in E. coli.     
The pET28b plasmid containing ipaD-ipaB and pACYCDuet-1 plasmid containing ipgC were 
constructed as follows. The ipaD gene was amplified by PCR using a 5’ primer with an NdeI 
restriction site and a 3’ primer with XhoI restriction site while the ipaB was amplified using a 5’ 
primer with XhoI site and a 3’ primer with BamHI site. The PCR products were digested and 
ligated into pET15b to form the ipaD-ipaB. The ipaD-ipaB fragment was then digested and 
ligated into similarly digested pET28b. The constructed pET28b plasmid was used to transform 
E. coli NovaBlue. The ipaD-ipaB and ipgC plasmids were then co-transformed into E. coli Tuner 
(DE3) for co-expression and both plasmids were selected using kanamycin and chloramphenicol. 
 Generation of plasmids for expression of the SipD-SipB fusion genes in E. coli.  The 
pET28b plasmid containing sipD-sipB and pACYCDuet-1 plasmid containing scAi were 
constructed as follows. The sipD was amplified by PCR using a 5’ primer with NdeI restriction 
site and a 3’ primer with SalI restriction site. The sipB was amplified using a 5’ primer with SalI 
site and a 3’ primer with XhoI site. The PCR products were digested and ligated into pET28b to 
form the ipaD-ipaB. The final pET28b construct was used to transform E. coli NovaBlue. The 
sipD-sipB and sicA plasmids were the co-transformed into E. coli Tuner (DE3) for co-expression 
and both plasmids were selected using kanamycin and chloramphenicol. 
 Generation of plasmids for expression of the tip protein and first translocator 
protein genes in E. coli.  The ipaD, sipD, lcrV, ipaB, sipB, and yopB genes were amplified by 
PCR using a 5’ primer with NdeI restriction site and a 3’ primer with BamHI restriction site. The 
PCR products were digested and ligated into pET15b. The constructed pET15b plasmids were 
used to transform E. coli NovaBlue. The plasmids containing the tip protein genes were then 
purified and used to transform E. coli Tuner (DE3). The translocator protein chaperone genes 
ipgC, sicA, sycD were copied by PCR and ligated into pACYCDuet-1 which was used to co-
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transform E.coli Tuner (DE3) for co-expression. Bacteria containing both both plasmids were 
selected using ampicillin and chloramphenicol. 
 Generation of plasmids for expression of PA-first translocator protein genes in E. 
coli.  The ipaB, sipB, yopB genes were amplified by PCR using a 5’ primer with NdeI restriction 
site and a 3’ primer with BamHI restriction site while the pa (encoding the L. lactis peptidoglycan 
anchor peptide) was generated using both 5’ primer and 3’ primers with NdeI sites. The PCR 
product was digested and ligated into pET15b to form the pa-ipaB pa-sipB and pa-yopB. The 
constructed pET15b was used to transform E. coli NovaBlue cell line. The cognate translocator 
protein chaperone genes ipgC, sicA, sycD were cloned into pACYCDuet-1 and used to co-
transform E. coli Tuner (DE3) for co-expression (except for pa-yopB/sycD which is transformed 
into the E. coli C43 strain) and both plasmids were selected using ampicillin and 
chloramphenicol. 
 Expression and purification of DB fusion Protein.  Tuner(DE3) cells  containing 
pET28b-IpaD/IpaB and pACYC-IpgC were grown at Auto-Induction media for 16hours started 
from a 6-hour LB overday culture. The bacterial pellet was resuspended, the cells ruptured using 
a microfluidizer and centrifuged at 12000 rpm for 20 minutes at 4°C.  AEBSF protease inhibitor 
was added before microfludization. The IpaDB/IpgC complex was purified using Immobilized 
Metal Affinity Chromatography (IMAC) based on an N-terminal His-tag. This protein was 
further purified using Hydrophobic Interaction (HI) Chromatography and Anion Exchange 
Chromatography on an AKTA Explorer 10TM system. A second IMAC purification was 
performed that included the detergent octyl-oligooxyethelene (OPOE) at 2% v/V concentration to 
remove the chaperone from the IpaD-IpaB complex as described before [48]. Alternatively, the 
detergent N,N-dimethyldodecylamine N-oxide solution (LDAO) at 0.1% v/V concentration  was 
also used to remove the chaperone. Collected fractions were analyzed by SDS-PAGE and the 
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buffer was exchanged into PBS containing either 0.5% v/V OPOE or 0.05% v/V LDAO using 
PD-10 desalting columns. 
 Expression and purification of the SipDB fusion protein.  Tuner(DE3) cells  
containing pET28b-SipD/SipB and pACYC-SicA were grown in Terrific broth media and 
induced with IPTG when the OD reached 1.0. The bacterial pellet was resuspended, sonicated 
and centrifuged as above.  AEBSF protease inhibitor was added before microfluidizing.  
SipDB/SicA was purified using IMAC technology via the N-terminal His-tag. The partially 
purified protein was further purified using Anion Exchange Chromatography with a pH gradient 
on an AKTA Explorer 10TM system. A second IMAC purification was performed that included 
the detergent N,N-dimethyldodecylamine N-oxide (LDAO) at 0.1% v/V in the solution. Collected 
fractions were analyzed by SDS-PAGE and buffer exchanged into PBS with 0.5% v/V OPOE or 
0.05% v/V LDAO using PD-10 desalting columns. 
Expression and purification of the tip proteins.  Expression strains were grown in 
auto-induction media for ~16 hours and started from a 6-hour pre-culture. Bacterial pellets were 
resuspended , sonicated and centrifuged as above to obtain a supernatant fraction that contained 
the soluble protein. The His-tagged tip proteins were then purified on an IMAC system followed 
by anion exchange chromatography. The purified proteins were dialyzed into PBS.  
 Expression and purification of the translocator proteins.  IpaB and IpgC (IpaB/IpgC) 
were co-expressed using auto-induction media while SipB/SciA and YopB/SycD were co-
expressed using Terrific broth. The proteins were then purified on an IMAC system followed by 
HI chromatography (and anion exchange chromatography for SipB/SicA, but not YopB/SycD). A 
second IMAC step was applied for all three proteins to remove chaperones using buffers with 
0.1% v/V LDAO. The final products were dialyzed into PBS containing 0.05% v/V LDAO. 
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 Expression and purification of the tip-PA proteins and production of tip protein-
BLPs.  All the tip-PA proteins were produced by Mucosis at the company’s request. ipaD, sipD 
and lcrV were codon-optimized for L. lactis and sub-cloned into the L. lactis expression vector 
Ppa224, Pmuc052 and pPA3, respectively, with a C-terminal PA domain that results in 
recombinant proteins secreted into the culture medium.  The constructed plasmids were 
electroporated into L. lactis PA1001 and the proteins were purified from the clarified culture 
media using cation exchange chromatography. The proteins were then dialyzed into PBS. For the 
preparation of bacterium-like particles coated with antigen, the proteins were incubated with 
BLPs (prepared by Mucosis) at room temperature for 2 hours and washed thoroughly with PBS.  
The coating of the BLPs with antigen proteins was performed at Oklahoma State University.  The 
amount of protein bound to the BLPs was determined by using Coomassie stained SDS-PAGE 
gels containing a bovine serum albumin (BSA) standard and with standardized amounts of the 
protein of interest.  The final products were 85 µg of IpaD-PA, 45 µg of SipD-PA and 70 µg of 
LcrV-PA per mg BLPs. 
 Expression and purification of the PA-translocator proteins and production of 
translocator protein-BLPs.  All three translcoator proteins possessing a PA tag were expressed 
using Terrific broth for growth. The proteins harvested from the cells were firstly partially 
purified by IMAC. PA-IpaB/IpgC and PA-SipB/SicA were further purified using anion exchange 
chromatography followed by a second IMAC to remove their chaperone with 0.1% v/V LDAO. 
The final products were dialyzed into PBS containing 0.05% v/V LDAO. PA-YopB/SycD was 
further purified with size exclusion chromatography with PBS containing 0.05% v/V LDAO. The 
final translocator protein products were incubated with naked BLPs at room temperature for 2 
hours and washed thoroughly with PBS 0.05% v/V LDAO. The amount of proteins bound to 
BLPs was determined similar to tip-BLPs using the corresponding PA-translocator protein as 
standard proteins.  
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 Biophysical characterization sample preparation. The proteins used in biophysical 
analyses were dialyzed into 20mM Citrate/20 mM Phosphate (CP) buffer with an ionic strength 
of 150mM and the pH was adjusted from 3.0 to 8.0 with either 0.5% v/V OPOE or 0.05% v/V 
LDAO added to the CP buffer as described in the results section for translocator protein 
preparations. The dialyzed protein was then filtered with 0.22 µm Millex Syringe-driven filter. 
The concentration of IpaDB fusion and SipDB fusion was adjusted to 0.1mg/ml. Tip proteins, tip-
PA proteins and PA-translocators were adjusted to 0.15 mg/mL and translocator proteins were 
adjusted to 0.3 mg/mL for the biophysical studies. 
For the protein-BLPs, they were centrifuged and resuspended with 20mM Citrate/20 mM 
Phosphate (CP) buffer with an ionic strength of 150mM and the pH adjusted from 3.0 to 8.0, 
0.05% v/V LDAO was added to the CP buffer, if required. The process was repeated three times 
to thoroughly wash the protein-BLPs. All the protein-BLPs (IpaD-BLPs, IpaB-BLPs, SipD-BLPs, 
SipB-BLPs, LcrV-BLPs and YopB-BLPs) samples were diluted to 1 mg BLP/mL. 
 Far-UV Circular Dichroism (CD) spectroscopy.  Circular Dichroism (CD) spectra of 
all the protein samples in CP buffer with or without the detergents OPOE (0.5%) or LDAO 
(0.05%) at six different pH values (3.0-8.0) were measured using a Jasco J-815 CD spectrometer 
equipped with a six-position Peltier temperature controller and coupled with six 0.1-cm path 
length cuvettes. The spectra were collected from 260 to 190 nm at 10 °C with a scanning speed of 
50 nm/min, a 1.0-nm resolution and three data acquisitions. Thermal unfolding was measured by 
collecting the CD signal at 222 nm (225 nm for protein bound to BLPs) every 2.5 °C with the 
temperature increasing from 10°C to 90°C, employing a temperature ramp rate of 15 ˚C/h. 
Samples were equilibrated to the target temperature (± 0.1 ˚C) for 5 s prior to each data point 
measurement. Two repeats were obtained and all three sets of signal data were converted into 
molar ellipticity and plotted (Jasco Spectral manager and Origin 8.6).  For protein associated with 
the bacterium-like particles (BLPs), the CD signal was plotted instead of molar ellipticity. 
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The calculation of converting CD signal into molar ellipticity is shown below: 
Molar ellipticity θ   


     (1) 
where θ represents CD signal in mDeg, M represents molecular weight of the protein, C is the 
concentration of protein in mg/mL, l is path length in cm, n is the number of amino acid residues 
present in the protein, whereas 100 is a factor to convert path length from cm into meters and 
1000 is a factor to convert raw CD signal from mDeg to Degrees.  
 Intrinsic tryptophan (Trp) fluorescence spectroscopy.   Intrinsic Trp fluorescence 
spectra of all the samples were obtained using a Photon Technology International (PTI) 
spectrofluorometer (Birmingham, New Jersey) equipped with a turreted 4-position Peltier-
controlled cell holder. Trp residues were excited primarily at the wavelength of 295 nm and the 
emission spectra were collected from 300 to 400 nm with a step size of 1 nm and a 0.5 s 
integration time. Samples in CP buffers in the presence of 0.5% OPOE or 0.05% LDAO (when 
needed) at different pH values from 3 to 8 were placed in quartz cuvettes with 1-cm pathlengths 
and the emission spectra were acquired from 10 to 85 °C with an increase of 2.5 °C. Three 
readings were taken for each sample and a spectrum of blank buffer at each pH was subtracted 
from the sample spectra. Peak positions were obtained using Origin software and a mean spectral 
center of mass method. The emission peak position calculated by the msm method reflects the 
changes but not the actual value - a 10-14 nm shift occurs during the analysis.  
 Static Light Scattering.  Static light scattering (SLS) provides a measure of thermally 
induced aggregation of proteins. These measurements were acquired simultaneously with 
intrinsic Trp fluorescence measurements using a second detector oriented 180˚ from the 
fluorescence photomultiplier tube but still 90˚ relative to the excitation source. Light scattering 
intensity at 295 nm was monitored as a function of temperature every 2.5 ˚C over a temperature 
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range of 10 to 85 ˚C. Buffer scans were subtracted from the sample readings prior to data 
analysis.  
Three-index Empirical Phase Diagrams (EPDs).  The substantial amount of thermal 
stability data acquired from the multiple techniques for each protein sample were summarized for 
global analysis using a three-index empirical phase diagram (EPD) to provide a comprehensive 
overview of the data using a standardized red, green and blue (RGB) color scheme. Briefly, 
structural indices defined as correlation of the degree of structural change within a given range of 
environmental stress conditions, are calculated for each data set. In this study, the secondary 
structural index was calculated from the 222 nm CD molar ellipticity (225 nm for protein 
associated with BLPs), the tertiary structural index was calculated from intrinsic Trp fluorescence 
peak position data and the aggregation index was calculated from the static light scattering data. 
The values for the structural index for a particular data set were normalized from 0 to 1, in which 
1 represents native secondary or tertiary structure while 0 represents extensively altered 
secondary or tertiary structure. A value of 0 for aggregation index indicates no aggregation while 
a value of 1 indicates the maximum extent of aggregation seen. Each of these structural indices 
was assigned to a color in the standardized RGB color scheme to yield a map that provides a 
correlation between color and physical state of the protein at a given pH and temperature. In this 
case, the strongest negative CD signal represents the largest amount of secondary structure and is 
assigned to red while the weakest signal is assigned to black. For fluorescence peak position data, 
the native tertiary structure is assigned to green and the most shifted wavelength is black. 
Aggregation is represented by static light scattering where the minimum signal is assigned to 
black assuming there is no or minimal aggregation while the highest level of aggregation seen is 
assigned to blue. The contribution of each RGB component can be seen in the right hand panels 
next to the associated EPD. The three-index EPDs can then be interpreted as follows: Yellow (i.e. 
the sum of the “native state” colors) is associated with the native state of a protein where both 
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secondary and tertiary structures are intact and no aggregation has occurred. Black is associated 
with significantly unfolded states with minimal retention of secondary and tertiary structure and 
no aggregation. Blue is associated with aggregated states with minimal secondary and tertiary 
structure and maximal aggregation. Finally, brown is associated with intermediate states of a 
protein with an intermediate loss of secondary and tertiary structure. 
 Analytical ultracetrifugation.  This approach was performed by collaborators at the 
University of Kansas. Fusion proteins were purified and the concentrations were adjusted to 8 µM 
in PBS at pH 7.4 containing 0.5% OPOE or 0.05% LDAO and covalently crosslinked by the 
addition of the amine-reactive crosslinking agent dithiobis[succinimidyl propionate (DSP). The 
reaction was maintained for 15 min at room temperature and quenched using 70 mM Tris-HCl 
pH7.4. The detergent was then removed by dialysis into PBS at pH 7.4. Sedimentation velocity 
analytical ultracentrifugation (SV-AUC) experiments were performed using a Beckman 
Proteomlab Optima XL-I analytical ultracentrifuge (Brea, California) equipped with a scanning 
UV/visible optical system housed in the Macromolecule and Vaccine Stabilization Center at the 
University of Kansas. Scans were collected at 20 ˚C after 1 hour of equilibration after the 
temperature was reached and at a rotor speed of 40,000 RPM with detection at 280 nm. Beckman 
charcoal-epon two sector cells with sapphire windows were used in an An-60 Ti 4 hole rotor. The 
data were analyzed using the Sedfit program by Peter Schuck. The default partial specific volume 
of 0.73 mL/g was used in the analysis, as well as values for buffer density and viscosity that were 
calculated using Sednterp based on buffer composition. A continuous c(s) distribution was used, 
with 280 scans. A range of 0 svedbergs to 15 svedbergs was used for LDA-DB and a range of 0 
svedbergs to 50 svedbergs was used for OPOE-DB, after verifying that there was no material 
sedimenting outside of these ranges. A resolution of 400 points per distribution was used, with a 
confidence level of 0.95. A best-fit frictional ratio of 1.43 was used for LDAO-DB, and a best-fit 
frictional ratio of 1.51 was used for OPOE-DB. Baseline, radial independent noise, a and time 
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independent noise were also fit, while the meniscus and bottom positions were set manually. The 
monomer peak was assigned by comparing the experimentally observed sedimentation 
coefficients to the maximum theoretical sedimentation coefficient of the monomer, calculated 
based on molecular weight. The oligomeric state of other observed species were determined by 
dividing the experimentally observed sedimentation coefficient of the oligomer by that of the 
monomer. Percent mass assigned based on integration of the c(s) peaks in Origin. The 
sedimentation coefficients reported are peak maxima.  
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CHAPTER III 
 
CONSTRUCTION AND BIOPHYSICAL CHARACTERIZATION OF A NOVEL DB FUSION 
COMPLEX FROM SHIGELLA FLEXNERI AS A CANDIATE SUBUNIT VACCINE 
 
Introduction 
Shigella spp. are the causative agents of shigellosis, a severe diarrheal and dysenteric 
disease having high morbidity and mortality among children and the elderly in developing 
countries. As a Gram-negative bacterial pathogen, Shigella is transmitted by the fecal-oral route. 
It is estimated to take only 10 to 100 organisms to cause an infection in humans [4]. There are 
four species of Shigella (S. flexneri, S. sonnei, S. dysenteriae and S. boydii) and there are 
approximately 50 serotypes within the genus [21,49], due to the different structures found in the 
O-antigen portion of the outer membrane lipopolysaccharide (LPS). Because serotype largely 
drives the host immune response during the course of natural infection, developing shigellosis 
due to one serotype of Shigella does not protect someone from infection by another serotype. 
Furthermore, this makes it difficult to develop a broadly protective vaccine that protects against 
all serotypes. Nevertheless, a common virulence factor called the type III secretion system 
(T3SS) is required for the pathogenesis of all Shigella serotypes.  The T3SS is also an essential 
virulence factor for many other important Gram-negative pathogens. Components of the Shigella 
T3SS are encoded on a 220-kb invasion plasmid and they lead to the assembly of a type III 
secretion apparatus (T3SA) [50]. This plasmid also encodes the majority of the effector proteins 
secreted by the T3SS and their cognate chaperones. 
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The T3SA is a syringe-like structure comprised of three parts: a basal body anchoring the 
apparatus into the bacterial envelope; an external needle; and a needle tip complex that functions 
in secretion control [4,18]. Upon host cell contact, the T3SA recognizes effector proteins at the 
cytoplasmic face of the apparatus. The effectors are then separated from their chaperone and 
passed through the base, the needle and ultimately through a translocon pore that is formed in the 
host cell membrane by the needle tip complex. The T3SS plays an essential role in Shigella 
pathogenesis by killing macrophages immediately after crossing the epithelial layer of the large 
intesting and inducing subsequent internalization of the bacterium into colonic epithelial cells 
[51,52]. As a shared and highly conserved virulence factor among all Shigella species, T3SS 
proteins are potential candidates for the development of a serotype-independent vaccine against 
shigellosis. 
Although much effort has been put into the development of vaccines against Shigella, no 
approved vaccine is yet available for prevention of shigellosis [22,25,26]. Our previous studies 
have demonstrated that a promising vaccine candidate is a novel fusion protein composed of 
highly conserved full length T3SS proteins IpaD and IpaB [48]. IpaD is located on the tip of the 
T3SA needle where it controls recruitment of other T3SA/T3SS components during translocon 
pore formation and host cell invasion [33,53]. Meanwhile, IpaB is part of the multimeric 
translocation pore that interacts with and inserts into the host cell membrane [54]. IpaB also 
mediates macrophage apoptosis after the pathogen is internalized into macrophages [11]. IpaD 
and IpaB have been shown individually to be protective antigens when delivered intranasally and 
intramuscularly to mice that were then challenged using the mouse lethal pulmonary infection 
model [37]. The development of a fusion protein sets the stage for including multiple antigens 
into one recombinant polypeptide which is more easily formulated than the two antigens 
separately. This is significant for a vaccine formulation targeting developing world since multiple 
antigens are delivered simultaneously and at an overall reduced cost.  The fusion of IpaD with 
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IpaB led to what is referred to as the ‘DB Fusion’. The DB Fusion was delivered through 
intranasal route and generated similar antibody titers to the IpaD/IpaB combination, however, 
higher levels of IL-17 were observed and this cytokine appears to be essential for protection 
against Shigella infection. S. flexeri, S. sonnei and S. dysenteriae were used for the lethal 
pulmonary challenge and an efficient protection was provided in each case [48]. 
Because the DB Fusion appeared to be a promising candidate for vaccine development 
against Shigella infection, a stable subunit vaccine formulation study was initiated. The work 
presented in this chapter focuses on the construction and preformulation characterization of this 
novel protein construct. The structural characteristics and stability of the DB Fusion were studied 
as a function of pH and temperature using biophysical techniques that included Circular 
Dichroism spectroscopy, intrinsic fluorescence spectroscopy and static light scattering. The data 
set obtained were combined and visualized using a novel three-index empirical phase diagram 
(EPD) that allowed analysis of the overall structural integrity and conformational stability of the 
protein. Because the DB Fusion only remains soluble in the presence of detergent, a mild 
detergent n-octyl-poly-oxyethylene (OPOE) was used in the biophysical studies presented in this 
chapter. An alternative detergent, Lauryldimethylamine-oxide (LDAO), was also used and found 
to give the DB Fusion distinct biophysical characteristics including enhanced plasticity (structural 
resilience) and even improved immunogenicity.  
 
Results 
DB Fusion protein construction and purification 
Much like its component IpaB [50,55], the DB Fusion was only successfully made by 
coexpressinig it with the Shigella chaperone protein IpgC. It then required a mild detergent such 
as OPOE or LDAO to separate the protein from the chaperone. The constructed DB Fusion is a 
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large 101.2-kDa protein comprised of both full-length IpaD and IpaB with a two-amino acid 
linker (Fig. 3.1A and B). To maintain solubility, the DB Fusion requires the presence of detergent 
(0.5% OPOE or 0.05% LDAO which is above their individual critical micelle concentrations, 
respectively). Far-UV CD spectroscopy was used to investigate the protein secondary structure 
content and thermal stability of the secondary structures of IpaD, IpaB, and the DB Fusion. 
Dominant minima at 208 and 222 nm were observed in all cases indicating the proteins contain 
significant amount of α-helical secondary structure (Fig. 3.1C). This suggests that the fusion 
protein maintains a properly folded secondary structure after all the purification processes. The 
secondary structure thermal stabilities of all three proteins were measured by CD melt monitoring 
mean residue molar ellipticity at 222 nm as a function of temperature (Fig. 3.1D). As with the 
previously published data [33,56], IpaD had two transitions at 60°C and 80°C while IpaB had a 
transition at ~58°C. A major transition was found at 60°C for the DB Fusion suggesting it has 
characteristics intermediate to IpaD and IpaB. This is further confirmed that the DB fusion mean 
residue molar ellipticity values for far-UV CD scans and thermal melt curves lie between those 
for IpaD and IpaB alone. 
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Figure 3.1 : Generation and initial biophysical analysis of the DB Fusion [48]. (A) The plasmid 
construct harboring the IpaD/IpaB fusion is shown. Restriction sites used for cloning are shown 
within a map of the commercial express plasmid pET28b. (B) Comparative SDS-PAGE profiles 
of IpaD, IpaB, and the DB Fusion is shown with molecular mass markers, in kDa, indicated to the 
left. (C) The CD spectra for IpaB in 0.5% OPOE, IpaD in PBS, and the DB fusion prepared in 
0.5% OPOE all indicate predominantly α-helical contgent with the mean residue molar ellipticity  
([q]R) values (measured in degrees cm2per decimol). (D) Thermal unfolding of the secondary 
structures of the DB fusion, IpaB, and IpaD as a function of temperature is shown. 
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Secondary structure stability 
To analyze the secondary structure stability of the DB Fusion, different pH conditions 
were applied to the protein for subsequent testing of thermal stability (Fig. 3.2). CD spectra of the 
DB Fusion in the presence of OPOE and LDAO at 10°C (Fig. 3.2 A and E, respectively) display 
double minima at 208 and 222 nm, which indicates the protein contains significant amounts of α-
helical structure across the entire pH range tested. A decrease in CD signal is observed in lower 
pH (pH 3, 4 and 5) conditions compared to the neutral pH conditions in OPOE indicating the 
average structure of the protein at acidic pH is slightly altered, however, the DB Fusion in OPOE 
shows a more intense signal overall the fusion in LDAO. 
The CD melts for the DB Fusion in OPOE or LDAO indicate a loss of α-helical structure 
since the molar ellipticity at 222 nm increases as the temperature is increased (Fig. 3.2 B and F, 
respectively). For the DB Fusion in OPOE, however, the secondary structure starts a major 
transition at ~55°C under acidic pH conditions and at ~60°C under neutral pH.  There is 
significant secondary structure loss after the major transition in all cases. Meanwhile, the DB 
Fusion in LDAO shows a lower degree of structure alteration as a function of temperature. A 
gradual linear increase is present for samples at pH3-5 without apparent transition, while protein 
at pH6-8 there is a subtle transition at around 50°C. Although a structural alteration occurs, the 
DB Fusion in LDAO maintains significant secondary structure under all the experimental 
conditions used here.   
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Figure 3.2 : Biophysical characterization data for the DB Fusion in the presence of OPOE (A, B, 
C and D) and LDAO (E, F G and H). The far-UV CD scan for the DB Fusion from pH 3 to pH 8 
indicates predominantly α-helical content with the mean residue molar ellipticity  ([q]R) values at 
10 °C (A, E). Thermal unfolding of the secondary structures of the DB fusion CD molar 
ellipticity at 222 nm monitored as a function of temperature from 10 to 90 ˚C (B, F). Intrinsic Trp 
fluorescence peak position wavelength (C, G), and light scattering intensity monitored at 295 nm 
as a function of temperature from 10 to 85 ˚C (D, H). Error bars represent standard deviation 
from three different experiments. Symbols: pH 3 (■), pH 4 (□), pH 5 (●), pH 6 (○), pH 7 (▲) pH 
8 (∆). 
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The CD spectra of the DB Fusion in both detergents after the thermal unfolding process 
were also measured and compared to the spectral data before unfolding to further investigate 
protein stability. These spectra were taken with the temperature returned to 10°C. The α-helical 
secondary structure of the DB Fusion in the presence of OPOE is clearly lost following the 
unfolding event (Fig. 3.3A, open symbols), however, the spectra of the DB Fusion in LDAO after 
prior unfolding and renaturation overlay perfectly with that generated before the thermal 
unfolding process (Fig. 3.3B). This provides strong evidence that the protein recovers its 
secondary structure fully. 
Tertiary structure stability 
Tertiary structure changes in the DB Fusion in the presence of OPOE or LDAO were 
characterized by monitoring changes in the intrinsic Trp fluorescence peak position wavelength 
as a function of temperature and pH (Fig. 3.2 C and G). The DB Fusion contains five Trp 
residues, four from IpaD and one from IpaB. For the DB Fusion in 0.5% OPOE (Fig. 3.2C), 
initial peak position at pH 3 was near 342 nm, which indicates only partial burial of Trp residues 
(on average) probably due to conformational alterations under these acidic conditions. As the 
temperature increases, a subtle red shift appeared followed by a blue shift after 65°C which is 
probably due to burial of indole side chains caused by aggregation. Peak positions of samples at 
pH4 to 8 are near or under 340 nm, which suggests that the Trp residues are largely buried. A red 
shift was obvious as a function of temperature in the beginning at these pHs, suggesting increased 
exposure of Trp residues to the polar aqueous environment. At pH 4, two transitions are seen, one 
at around 32°C, indicating formation of a conformationally altered state, and another at 65°C, 
suggesting aggregation (which was later confirmed by static light scattering). Samples at pH  to 
pH 8 behave similarly with a transition at approximately 55~60°C, however, a sharp transition is 
observed at pH5, while samples showed a red shift from pH 7 to pH 6 and pH 8, suggesting the 
protein is most stable at pH 7.  
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Figure 3.3 : Far UV Circular Dichroism spectra for DB fusion before and after thermal melt of 
the secondary structure.  The DB fusion with the presence of PBS 0.5% OPOE (A) and 0.05% 
LDAO (B) were used for circular dichroism spectrum at 10 °C before (■) and after (▲) thermal 
denaturation. 
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In the presence of LDAO, the DB Fusion behaved differently (Fig. 3.2G and H). For all 
samples the Trp emission maxima at 10°C are higher than 345nm and showed a gradual red shift 
as the pH increased, suggesting the indole side chains are only partially buried at the start and 
gradually become more exposed to the aqueous environment at higher pHs. As a function of 
temperature the peak position wavelength increased linearly without any obvious transitions 
which can be attributed to an intrinsic thermal effect on the internal conformational alteration of 
the Trp residues. Thus, no major structural transitions are indicated.   
 
Quarternary structure stability 
Static light scattering measurements were performed simultaneously with the intrinsic 
fluorescence to examine the aggregation behavior of the DB Fusion protein (Fig. 3.2 D and H). 
The DB Fusion in the presence of OPOE undergoes aggregation at all pHs tested with the onset 
of aggregation at pH 3 to 5 are seen at around 35°C while samples at pH 6 to 8 didn’t start to 
aggregate until 55°C. The decrease of the signal after the initial red fluorescence shift suggests 
that aggregation leads to precipitation of the protein which then settles out of solution at 
approximately 60°C for samples at pH 4 to 7, and around 70°C for samples at pH 3 and pH 8. 
The static light scattering data indicate the DB Fusion maintains highest stability in relative 
neutral environment with regard to aggregation. No significant increase in light scattering is 
observed as a function of temperature and pH for the DB Fusion in LDAO, indicating no 
significant aggregative behavior. These data are consistent with the results from intrinsic 
fluorescence which show that the DB Fusion is significantly stabilized by the presence of LDAO.  
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Three-index empirical phase diagram (EPD) provides an overall assessment of the biophysical 
stability of the DB Fusion 
A data visualization approach, the three-index empirical phase diagram (EPD), was 
generated using the datasets obtained from far-UV CD spectroscopy, intrinsic Trp fluorescence 
spectroscopy and static light scattering as a function of temperature and pH. This was done for 
the DB Fusion protein with the presence of OPOE and LDAO. In the three-index EPDs, different 
colors are assigned to the changes in different protein structural states. Red is assigned to 
secondary structure (molar ellipticity at 222nm), green to tertiary structure (Trp fluorescence peak 
position wavelength), and blue to quaternary structure or aggregation (light scattering intensity at 
295nm). 
For the DB fusion in OPOE, the EPD can be divided into four phases (Fig. 3.4A). Phase 
1 is the yellow region covering pH 6 to pH8 below 55°C, pH 5 below 45°C, and pH 4 below 
30°C. This portion of the EPD suggests that the fusion protein stays in its most stable native state 
here, which is consistent with the presented CD and fluorescence data. In phase 2, the dark color 
defines the samples in a highly structurally altered state (secondary and tertiary structure are lost) 
with a lower degree of aggregation compared with phase 4. Phase 3 indicates that the protein 
samples are in a partially unfolded state either because of relatively high temperature (pH 6-8) or 
due to acidic environment (pH 3-5). The blue color of phase 4 suggests the acidic pH and high 
temperature cause complete aggregation. Overall the DB Fusion protein is maintained in its most 
stable state at around neutral pH and below 55°C in OPOE.  
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Figure 3.4 : Three index empirical phase diagram (EPD) for DB fusion with presence of 0.5% 
OPOE (A), and 0.05% LDAO (B), representing conformational stability of the DB Fusion as a 
function of pH and temperature. Data obtained from multiple techniques shown in Figure 3.2 
were synthesized into this colored map with different physical states represented by different 
colors. Four different phases were defined for the DB Fusion with 0.5% OPOE. Region A1: most 
favorable state of the protein. Region A2: Relatively unstable states at either low pH or high 
temperature. Region A3: transition state between different phases. Region A4: completely 
unfolded and aggregate state. On the other hand, the EPD of the DB Fusion in 0.05% LDAO 
shows no clear transition states and three phases with borders characterized by subtle transitions 
were defined. Regions B1 and B2 are relatively favorable states and B3 is a relatively unfavorable 
structural state.  
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The three-index EPD of the DB Fusion in the presence of LDAO shows a pattern that is 
quite distinct from that in OPOE (Fig. 3.4B). As temperature increases, all measurements (except 
for static light scattering) show gradual and constant changes without sharp color divisions. This 
is consistent with the presented biophysical data. Since there is no drastic change, it is hard to 
find clusters over temperature extremes except the difference between pH 3-5 and pH 6-8. Data at 
pH 3-5 show more apolar microenvironments around the Trp residues (indicated by fluorescence 
peak position) and less secondary structure (CD) than pH 6-8 in the lower temperature region. No 
aggregation is observed across all the pH and temperature ranges tested in LDAO.  
 
Chemical stability of DB fusion at 50 °C incubation 
The high throughput biophysical techniques used here provide evidence that the DB 
Fusion with OPOE is stable at neutral pH under 55°C, but the DB Fusion in LDAO behaves quite 
differently. To further expand these studies by exploring the chemical stability of the two 
proteins, the DB Fusion in PBS with either OPOE or LDAO was incubated at 50 °C and 
monitored for 7 days. Samples were removed daily and the same amount of protein was subjected 
to SDS-PAGE with Coomassie staining (Fig. 3.5). The DB Fusion in OPOE (Fig. 3.5A) started 
degrading at day one and more than 90% of protein was lost by day five.  Meanwhile, the DB 
Fusion in LDAO (Fig. 3.5B) also showed mild degradation, but approximately 50% of the protein 
remained in its full-length form even after 7 days. This phenomenon indicates that even though 
the DB Fusion in LDAO is in a different structural state than in OPOE, it maintains this state 
stably and even shows signs of greater chemical stability.  
 
 
 
  
 
 
Figure 3.5 : The DB Fusion chemical stability was examined after storage at 50
Fusion in PBS containing either 0.5% OPOE (A) and
for 7 days.  Samples were taken each day and same amount of sample for each was subjected to 
SDS-PAGE and stained with Coomassie blue. The densitometry of the DB fusion protein band 
were taken and the percentage of p
PAGE gel. 
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 0.05% LDAO (B) was maintained at 50 °C 
rotein remained were calculated and labeled below the SDS
 
 
 °C.  The DB 
-
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Analytical ultracentrifugation to determine the association state of DB fusion 
To better understand the effect of different detergents on the DB Fusion, sedimentation 
velocity analytical ultracentrifugation was conducted to compare the oligomerization state of the 
soluble DB Fusion in the presence of OPOE (Fig. 3.6A) or LDAO (Fig. 3.6B). The DB Fusion in 
OPOE and DB Fusion in LDAO were cross-linked and dialyzed into PBS without detergent and 
subjected to AUC analysis to provide an accurate measurement of sedimentation. Because the 
sample contained some degradation products, a contaminant peak showed up for each sample, 
however, the DB Fusion in LDAO contained a dominant monomer peak with a sedimentation 
coefficient of 4.82 s, and then a dimer (7.03 s) and linear trimer (9.6 s). The sedimentation 
velocity results for the DB Fusion in OPOE were more complicated and were analyzed by c(s) are 
shown in Figure 5B and Table 3.1. Although a trimer is not indicated in Table 3.1, a different 
scale reveals a shoulder on the 11.15 s peak at about 9.8 s (data not shown), the sedimentation 
coefficient expected of a trimer. There were many higher order aggregates for the sample cross-
linked in OPOE, such as hexamers (15.29 s) and octamers (17.67 s) along with some other higher 
order species. Additionally, the trimer/tetramer peak was much larger in the OPOE-prepared 
sample, suggesting that this detergent favors the formation of oliogmers as was demonstrated for 
IpaB prepared in OPOE [57]. 
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Figure 3. 6 : Determination of the precise DB Fusion oligomerization state by analytical 
ultracentrifugation (AUC). The DB Fusion in 0.5% OPOE (A) and 0.05% LDAO (B) were 
chemically cross-linked and thoroughly dialyzed into PBS without any detergent. Sedimentation 
velocity AUC radial absorbance scans were obtained for each DB Fusion sample and analyzed 
using SEDFIT program. 
  
A B 
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Table 3.1. Sedimentation coefficient of each DB fusion species in the presence of LDAO or 
OPOE and the relative percent of mass that can be attributed to each DB Fusion species as 
determined by SV-AUC. 
In the presence of different detergents, the DB Fusion forms different species. In the presence of 
LDAO more than 50% of the species are monomeric, with some dimer and a little trimer 
formation. In contrast, the DB Fusion in OPOE forms various oligomers, with mostly trimers and 
tetramers.  
  
Species Sedimentation coefficient (Svedberg) 
Relative Percent of Mass for 
Each Species 
With LDAO   
Fragment 3.19 15% 
Monomer 4.82 54% 
Dimer 7.03 26% 
Trimer 9.60 6% 
With OPOE   
Monomer 5.01 16% 
Dimer 7.64 9% 
Trimer and tetramer 11.15 45% 
Hexamer 15.29 5% 
Octamer 17.67 3% 
Higher order aggregates 22.43 6% 
 
25.19 11% 
 
34.84 2% 
 
41.23 1% 
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Discussion 
Subunit vaccines are considered safer than live attenuated vaccines, especially in people 
with compromised immune systems and in children. As previously described, IpaD and IpaB 
have been shown to be protective antigens and are candidates for a possible subunit vaccine 
formulation containing multiple antigens. Unfortunately, there are several obstacles to overcome, 
such as defining appropriate formulation conditions for both antigens. This is often difficult and 
the cost of the production would be higher for two antigens relative a single recombinant protein 
[58]. The development of the novel recombinant DB Fusion protein as a Shigella vaccine 
candidate provides an alternative way to making a broadly protective vaccine that is more 
affordable, especially for the developing world. 
In this work, we successfully constructed a novel DB Fusion and obtained highly purified 
protein. A  band was found at around 50 kDa which proved to be degradation product containing 
parts of IpaD and IpaB based on western blot analysis (data not shown).  The conformational 
stability of the DB Fusion was extensively characterized by employing a variety of biophysical 
techniques. CD spectroscopy, intrinsic fluorescence spectroscopy and static light scattering were 
used to monitor the stability of protein at the secondary, tertiary and quaternary (aggregative) 
levels, respectively, as a function of temperature and pH. The large data set obtained was 
summarized in a three-index empirical phase diagram (EPD) which allows visualization of 
protein structure changes in response to environmental conditions via a graded color scheme. Due 
to the hydrophobicity of IpaB, the presence of detergent was necessary for maintaining the DB 
Fusion in solution during all of the biophysical analyses. The two different detergents considered 
were used just above their critical micelle concentrations (CMCs). Thus, we used 0.5% OPOE 
and 0.05% LDAO and found that they both led to very different properties in the DB Fusion. 
With OPOE, the DB Fusion lost the majority of its α-helical secondary structure after thermal 
unfolding regardless of the pH used. In contrast, the DB Fusion in LDAO maintained a 
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significant degree of secondary structure even after thermal unfolding followed by reducing the 
temperature back to 10°C. With regard to tertiary structure, the indole side chains of the five Trp 
residues of the DB Fusion in LDAO were more exposed than for the protein in OPOE, however, 
there was no sharp transition (indicating full unfolding) for the protein in LDAO compared to DB 
Fusion in OPOE. Furthermore, there was no observed aggregation for the DB Fusion prepared in 
LDAO under any of the conditions tested. Overall, the EPD profiles clearly indicated that in the 
presence of OPOE, the DB Fusion is most stable at pH 6 to 8. It starts to unfold sooner at lower 
pHs as the temperature is increased, and it completely aggregates after 60°C at pH 3 to 5. 
Meanwhile, in LDAO the protein is in a state that provides the protein more structural elasticity 
(resiliency) to adapt to a wide range of pH and temperature conditions. The pattern of EPD for the 
DB Fusion in LDAO indicates that the protein structure is less tightly packed than when it is in 
OPOE. This may be because LDAO is a non-denaturing zwitterionic surfactant with a positively 
charged N+ group and negatively charged O- group.  These groups might interact with charged 
protein residues located on the DB fusion protein surface but not disrupt the apolar core of the 
protein [56]. Despite the fact that LDAO interacts with DB fusion to impart a unique structural 
state, this does not appear to be the case for all proteins.  
Full development of a protein subunit vaccine requires formulation which often includes 
the identification of excipients that serve to stabilize antigen. Identification of excipients was not 
included in this study, but this will be done in future studies. Nevertheless, we have already 
progressed in the formulation of DB Fusion with the use of the detergent LDAO, which allows 
the protein to remain stable both physically and chemically. The effect that the two detergents 
used here (OPOE and LDAO) have on the DB Fusion’s structural state suggests that they interact 
with the protein differently. A previous study on detergent effects on IpaB indicated that IpaB in 
LDAO exclusively forms a monomeric species while IpaB in OPOE forms a distinct tetramer that 
may dimerize into an octomer [57]. Thus, we used analytical ultracentrifugation in this study 
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because it is very informative in the respect of evaluating hydrodynamic properties of 
biomolecules and macromolecular complexes [38]. It should be noted that AUC can be 
compromised by the difficulties posed by trying to remove all of the degradation from a protein 
preparation. Furthermore, degradation products can influence the accuracy and interpretation of 
AUC data since they could potentially associate with the full-length IpaB or the DB Fusion (or 
with each other to form higher order species). This is reflected in the AUC data presented here.  
The AUC data however still provided insight into the oligomerization state of the fusion in OPOE 
which differs markedly from that in LDAO. As with IpaB [56], the DB Fusion forms higher order 
quaternary species which is dominanted by a tetrameric form when in OPOE.  Meanwhile, the 
DB Fusion in LDAO favors the formation of a monomeric species. The effect of the detergents 
on the DB Fusion oligomerization status is very much in line with that of IpaB, but the reason 
behind this is not yet clear. 
Perhaps unlike many normally employed excipients, LDAO is believed to interact with 
the DB Fusion to alter its structure – apparently in a positive manner. This raises the concern that 
the structural alteration of the DB Fusion in LDAO may influence the immunogenicity of the 
protien. Moreover, as discussed above, the DB Fusion tends to favor an oligomeric form in the 
presence of OPOE, but a monomer is favored in the presence of LDAO. Some studies have 
shown that multimeric antigens tend to induce better memory immune responses than do 
monomeric antigens [59]. For the DB Fusion, this is clearly not the case. The DB Fusion in the 
presence of LDAO actually induces greater protection in a mouse model of shigellosis than its 
counterpart in OPOE.   
In summary, the novel DB Fusion protein is a promising Shigella vaccine candidate that 
is highly immunogenic and broadly protective (serotype and species independent). It provides an 
advantage over using IpaD and IpaB separately in that as a single protein it is less costly in its 
production. Moreover, this preformulation study has identified a detergent (LDAO) that appears 
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to provide enhanced biophysical and chemical stability. Perhaps most importantly, LDAO 
reduces (eliminates) the aggregative properties of the antigen which is highly undesirable for 
vaccine formulation because it reduces the likelihood of loss of efficacy/activity [60,61,62]. 
LDAO not only stabilizes the DB Fusion, it also increases the immunogenicity and is in line for 
testing in phase 1 human trials within the next two years. Nevertheless, basic research on this 
vaccine formulation must continue since the structural and immunogenic principles behind the 
phenomena observed here require further characterization. 
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CHAPTER IV 
 
CONSTRUCTION AND BIOPHYSICAL CHARACTERIZATION OF A NOVEL SipDB 
FUSION COMPLEX FROM SALMONELLA TYPHIMURIUM AS A CANDIDATE 
SUBUNIT VACCINE 
 
Introduction 
In addition to the Shigella spp. discussed in Chapter III, we have also worked with 
another important bacterial pathogen from the Enterobacteriaceae which falls into the genus 
Salmonella.  Salmonella spp. are gram-negative, motile, facultative intracellular, rod-shaped 
facultative anaerobes. The genus Salmonella consists of two species, Salmonella enterica and 
Salmonella bongori.  S. enterica  is the most commonly encountered cause of foodborne diarrhea 
with about 1.2 million illnesses and 450 deaths annually in the United States and more than 1.3 
billion cases annually worldwide [63,64].  There are more than 2500 serovars of S. enterica with 
three main groups involved in causing human disease.  There are 22 million cases of enteric fever 
with 200,000 deaths every year around the world.  These cases occur mostly in pre-school and 
school-age children.  S. enterica serovars Typhi and Paratyphi A and B are the main groups 
responsible for this disease [65,66,67].  A second group of serovars includes S. enterica serovar 
Choleraesuis and Paratyphi C, which are important causes of septicemia and multiple organ 
dysfunction in humans. The last group is known collectively as the non-typhoidal Salmonella 
(NTS), which is usually self-limiting in healthy humans but can be severe or even fatal in the very 
young, the elderly, and immunocompromised people.  NTS includes a large number of serovars, 
most
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notably S. enterica serovar Typhimurium (which I’ll refer to as S. typhimurium) and S. enterica 
serovar Enteritidis (which I’ll refer to as S. enteritidis) which are the most commonly encountered 
pathogens [68]. 
A lot of effort has been put into the development and formulation of vaccines against 
Salmonella, however, there is still no broadly protective S. enterica vaccine available which can 
protect across serovar boundaries. A live-attenuated S. typhi vaccine, called Ty21a, is available 
and confers cross-protection against S. Paratyphi B but not S. Paratyphi A.  The Ty21a vaccine 
requires three oral doses taken every other day, however, being a live vaccine, there are safety 
concerns for some individuals.  Another licensed vaccine in the U.S. is formulated based on the 
capsular polysaccharide of fully virulent S. typhi, but it is rather poorly immunogenic and only 
effective against S. typhi [69,70]. Neither of these licensed vaccines can be considered “broadly 
protective” since they do not protect against a wide range of Salmonella serovars.  
Just like Shigella and a number of other Gram-negative pathogens, Salmonella possesses 
a type III secretion system (T3SS) as an important virulence factor. In fact, it possesses two 
T3SSs encoded by two distinct gene clusters termed Salmonella pathogenicity islands 1 and 2 
(SPI-1 and SPI-2, respectively). The T3SSs are essential for the human infections caused by 
Salmonella [71,72,73]. The Salmonella SPI-1 T3SS is very similar to the Shigella T3SS and it is 
responsible for induction of membrane ruffles and invasion of epithelial cells [73,74,75]. 
Moreover, the SPI-1 T3SS is responsible for having a cytotoxic effect on macrophages during the 
early stages of infection [76].  The SPI-2 T3SS is also an essential virulence factor and it is 
associated with intracellular growth of Salmonella following SPI-1 mediated invasion [77,78,79]. 
After invasion of the host cell, the pathogen remains confined to the “Salmonella-containing 
vacuole” (SCV) and uses its SPI-2 T3SS to deliver effectors into the host cell cytosol for 
maintenance of the SCV where it grows until rupture and release from the cell [80]. 
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As mentioned above, the Salmonella SPI-1 T3SS is very similar to the Shigella T3SS. 
The Shigella T3SS tip protein IpaD and the first translocator protein IpaB have been shown to be 
effective as protective antigens using the mouse lethal pulmonary model for Shigella challenge 
[37]. Our previous studies have also demonstrated that we have successfully developed a 
promising vaccine candidate with a novel DB fusion protein composed of these two proteins [48]. 
The IpaD homolog from Salmonella SPI-1 is SipD which has been demonstrated to be localized 
on the Salmonella surface.  The IpaB homolog from SPI-1 is SipB which has been shown to be a 
cholesterol binding protein just like IpaB. Moreover, as with IpaD and IpaB, SipD and SipB are 
conserved across all the important Salmonella serovars. Thus, these proteins may be able to 
provide potential serotype independent protection when used for immunization. Inspired by the 
success of the IpaD-IpaB fusion from Shigella, I generated a novel SipD-SipB fusion protein 
whose construction will be described here. Successful expression of the SipDB fusion requires 
co-expressioin with SipB’s chaperone SicA.  The mild detergent N,N-lauryl dimethyl amine 
oxide (LDAO) is then used to separate the chaperone from the SipB portion of the fusion protein. 
In preparation for use of the protein in future vaccine formulations, the biophysical and chemical 
stability of the SipBD fusion was examined as a function of temperature and pH.  In the end, we 
found that in the presence of LDAO, the SipDB fusion behaves more stably than in other 
detergents with a high degree of plasticity, much like its counterpart from Shigella.  
 
Results 
SipDB fusion protein is expressed and stably purified with the presence of detergent LDAO 
As with construction of the Shigella DB Fusion, I introduced a two-amino acid linker 
between SipD and SipB protein when fusing the two proteins and I used the SipB chaperone SicA 
for co-expression with the final SipDB fusion. After an initial IMAC purification step followed 
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by a pH gradient anion exchange chromatography step, SicA was removed from the SipDB 
fusion with detergent (0.1% LDAO) followed by a second IMAC column.  The bound SipDB 
fusion was then eluted and maintained as a soluble fusion protein in 0.05% LDAO.  This 
concentration of LDAO was just above its critical micelle concentration (CMC) and was optimal 
in maintaining SipDB fusion solubility.  SDS-PAGE of SipD, SipB and SipDB fusion is shown in 
Fig. 4.1A.  The lower molecular weight bands in the SipDB fusion lane are minor degradation 
products of SipD and SipB as confirmed by western blot analysis.  Far-UV Circular Dichroism 
(CD) spectroscopy was then used to determine the secondary structure content of the SipDB 
fusion for comparison with the spectra of SipD and SipB individually.  The spectra of all three 
preparations showed double minima at 208 and 222 nm, indicating that the secondary structure of 
each protein is highly α-helical (Fig. 4.1B).  It is known that SipD is rich in α-helical secondary 
structure based on its crystal structure [81] and the N-terminal portion of SipB is highly α-helical 
[82] and both proteins have CD spectra that are in agreement with this. As for the SipDB fusion, 
these data strongly suggest that the protein is properly folded and stably purified. 
 
SipDB fusion with the presence of LDAO maintains secondary structure stability 
The protein secondary structure content and stability was further investigated using Far-
UV CD spectroscopy and thermal unfolding. At 10 °C the spectra of the SipDB fusion at pH3 
through pH8 all show a similar pattern with dominant minima at 208 and 222 nm, thus indicating 
significant α-helical content.  The protein shows a slightly stronger signal at pH values near 
neutral, suggesting a structural preference for this pH range (Fig. 4.2A).  
When the CD signal at 222 nm (a minimum seen for α-helical structures) was monitored 
as function of temperature, a gradual increase in signal without a clear transition to indicate full 
unfolding suggested that the SipDB fusion’s secondary structure  in the presence of LDAO was 
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thermostable at all pH values tested (Fig. 4.3A). This is similar to what was observed for the 
Shigella DB Fusion as discussed in Chapter III. Moreover, when the protein was cooled back 
down back to 10 °C, the CD spectrum at each pH was to the scan taken before the temperature 
increase.  These data suggest that just the SipDB fusion in LDAO not only maintains its 
secondary structure under extreme conditsoin, but it is also able to regain its original secondary 
structure content following thermal stress.  
 
Tertiary structure of SipDB with the presence of LDAO is more open but relatively stable 
Intrinsic Trp fluorescence spectroscopy was used to study potential tertiary structure 
changes in SipDB fusion as a function of environmental pH and temperature. Tryptophan is an 
intrinsic fluorophore found in many proteins that has emission properties that are sensitive to the 
immediate environment of the residue.  Thus, properties such as fluorescence intensity and peak 
position wavelength can be used to monitor changes to the overall or tertiary structure of a 
protein.  The fluorescence intensity of Trp in the SipDB fusion decreased gradually without any 
sharp transition, indicating the gradually exposure of the native Trp residues to the aqueous 
solvent as the temperature increased (Fig. 4.3B). Meanwhile, the peak position wavelength of Trp 
emission increased with the temperature at all pH conditions, which likewise indicates that the 
tertiary structure is entering a more open state that allows solvent exposure to the typically buried 
Trp residues (Fig. 4.3C).  At 10 °C, there is a gradual red shift that occurs as the pH increases, 
suggesting the Trp is more buried under acidic environmental conditions, but becomes more 
exposed at neutral pH.  Overall, the intrinsic Trp fluorescence spectroscopy shows that LDAO 
stabilizes the protein against sudden major unfolding events, which is consistent with what was 
observed for the secondary structure as monitored by CD spectroscopy. 
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Figure 4.1 : Purification and secondary structure analysis of the SipDB fusion protein from 
Salmonella. (A) SDS-PAGE of purified SipD, SipB, and the SipDB fusion protein.  The 
molecular mass markers are in the left lane with sizes labeled up to 100 kD.  (B) The Far-UV 
Circular Dichroism (CD) spectra for SipD, SipB, and the SipDB fusion in citrate-phosphate 
buffer (pH 7) after conversion to mean residue molar ellipticity ([q]R) values (measured in 
degrees cm2per decimol). For SipB and SipDB, 0.05% LDAO was included to maintain 
solubility.  The double minima at 208 and 222nm are present in all cases and are indicative of 
predominantly α-helical protein content within each of the proteins.   
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Figure 4.2 : Far UV Circular Dichroism (CD) spectra for the SipDB fusion at pH 3 to 8.  
These spectra were obtained in the presence of 0.05% LDAO before (A) and after (B) thermal 
unfolding at 90 oC.  The SipDB fusion was prepared in citrate-phosphate buffer in the presence of 
0.05% LDAO at each of the indicated pH values.  All of these spectra were obtain were obtained 
at 10 °C before or after thermal treatment and are expressed here as mean residue molar ellipticity  
([q]R) values (measured in degrees cm2per decimol).  Symbols: pH 3 (■), pH 4 (□), pH 5 (●), pH 
6 (○), pH 7 (▲) pH 8 (∆). 
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Figure 4.3 : Biophysical characterization data summary for SipDB fusion with the presence 
of LDAO. (A) Thermal unfolding was monitored by following the loss of secondary structure 
(via the minimum at 222 nm) for the SipDB fusion which is expressed as mean residue molar 
ellipticity as a function of temperature from 10 to 90 ˚C. (B) Intrinsic Trp fluorescence intensity 
changes were monitored as a measure of tertiary structure integrity as a function of pH and 
temperature. (C) Intrinsic Trp fluorescence peak position wavelength was monitored as a second 
measure of tertiary structure integrity as a function of pH and temperature. (D) Static light 
scattering intensity was monitored at 295 nm as a function of pH and temperature from 10 to 85 
˚C to measure protein quaternary structure or aggreation. Error bars represent standard deviation 
from three different experiments. Symbols: pH 3 (■), pH 4 (□), pH 5 (●), pH 6 (○), pH 7 (▲) pH 
8 (∆).  
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SipDB fusion protein aggregation  is prevented with the presence of LDAO 
Static light scattering (SLS) rises as the size of the particles being examined in a solution 
increase in size.  Thus, SLS provides a means for monitoring increases in quaternary status of a 
protein, which is typically an indicator of protein aggrergation.  Thus, aggregation of the SipDB 
fusion protein was investigated by SLS which was performed simultaneously with the intrinsic 
Trp fluorescence measurement (Fig. 4.3D). Consistent with observations for the Shigella DB 
fusion protein, there was no significant increase in static light scattering observed regardless of 
the various pH conditions used.  Similarly, no increase in light scattering was observed as the 
temperature was increased from 10 to 85 °C.  This indicates that no aggregation occurs for this 
protein during the thermal stresses applied here.  This is consistent with the intrinsic fluorescence 
data which suggested no major changes in tertiary structure which could expose the hydrophobic 
core and lead to aggregation of the protein.  This is also consistent with the observation that the 
SipDB fusion in LDAO can be heated to 90 oC and the cooled back to 10 oC where it retains its 
original secondary structure as indicated by CD spectroscopy.  
 
Three-index empirical phase diagram (EPD) visualizes the biophysical stability of SipDB fusion 
As discussed in chapter III, the three-index empirical phase diagram (EPD) provides a 
platform for combining a large amount of data into a single diagram that allows analysis of a 
protein’s shift between structural states.  The EPD approach as applied here summarizes the 
stability of a protein based on its secondary, tertiary and quaternary structures based on data 
obtained by CD spectrscopy, intrinsic Trp fluorescence spectroscopy and static light scattering.  
To improve this form of data visualization for analyzing changes in macromolecular structural, 
the three-index EPD assigns colors to different protein structural states so that a meaningful 
relationship between color and molecular features can be formed.  In this case, red is assigned to 
secondary structure, green is applied to tertiary structure, and blue is assigned to aggregation. 
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The three-index EPD for the SipDB fusion prepared in LDAO exhibits a pattern that is 
very similar to that of the Shigella DB fusion prepared in LDAO (Fig 4.4). As temperature 
increases, CD and intrinsic Trp fluorescence spectroscopies indicate constant, gradual changes in 
secondary and tertiary structure, respectively, without any sharp structural transitions or changes 
occurring.  This is indicated by the gradual shifts in color in Figure 4.4 (top and middle panels on 
the right, respectively) and this is consistent with the biophysical measurements presented in 
Figure 4.3 (panels A-C). Due to the resistance to aggregation, no color change is observed for 
light scattering in the EPD (Fig. 4.4, bottom right panel).  When these data are considered as a 
whole, there is no drastic color change in the combined diagram except for the difference between 
low pH conditions (pH 3 to 5) and high pH conditions (pH 6 to 8).  At lower temperature region, 
the protein secondary structure is more partially unfolded at low pH than at high pH.  Meanwhile, 
the Trp is slightly more buried at lower pH, perhaps indicating that the protein tertiary structure is 
somewhat more open at pH values of 6 and higher. It is difficult to define conformational clusters 
that are dependent upon the temperature increase. This pattern is also observed for the Shigella 
DB fusion prepared in the presence of LDAO.  Considering the two components of SipDB fusion 
are quite similar to their homologous IpaD and IpaB counterparts from Shigella, and they are 
fused here using strategy similar to that of the Shigella DB Fusion, it’s not surprising that we 
obtained this result.  For the Shigella protein, this was quite distinct from what was observed in 
the presence of the detergent octyl polyoxyethylene (OPOE) in which the DB Fusion displayed 
clear structural transitions in response to elevated temperature and these were not reversible.  A 
similar study in OPOE was not performed on the Salmonealla SipDB fusion protein because the 
prior work with Shigella proteins indicated that LDAO was the detergent that would be used in 
future vaccine formulations.   
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Figure 4.4 : Three index empirical phase diagram (EPD) for SipDB fusion with presence of 
0.05% LDAO, representing conformational stability of the SipDB fusion as a function of pH and 
temperature. Data obtained from multiple techniques shown in Figure 4.3 were synthesized into 
this colored map with different physical states represented by different colors. EPD of SipDB 
fusion shows no clear transition state and the state of the protein gradually altered as the 
temperature increase. 
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Discussion 
A tremendous amount of effort has been expended for the development of vaccines 
against Salmonella, however, much of the research focus here has been on generating live, 
attenuated vaccine strains that, in the end, always give rise to serotype-specific immunity.  Thus, 
a broadly protective vaccine is strategy is needed.  As described in Chapter III, we have 
successfully constructed a subunit vaccine called DB fusion – a fusion protein consisting of IpaD 
and IpaB from Shigella, which are homologous to the T3SS proteins SipD and SipB, respectively, 
from Salmonella.  The DB Fusion was shown to protect against all Shigella species and serotypes 
tested.  Inspired by this success, a Salmonella version of the DB Fusion, called the SipDB fusion, 
was created.  The hydrophilic SipD portion is not sufficient to maintain the whole fusion protein 
soluble due to the hydrophobic characteristics of the SipB portion (data not shown).  Thus, the 
SipDB fusion had to be co-expressed with the SipB chaperone, SicA.  The SicA could then be 
removed using the detergent LDAO.  LDAO is a mild detergent, was previously found to 
stabilize the Sihgella DB Fusion and, more importantly, it imparted an improved immune 
response on the DB Fusion.  Thus, we immediately elected to use LDAO as the detergent for 
removing SicA from the SipDB fusion and to maintain its solubility.   
In this study, a battery of biophysical techniques was used to characterize the 
conformational stability of the SipDB fusion in the presence of LDAO.  The techniques used here 
included Far-UV CD spectroscopy, intrinsic Trp fluorescence spectroscopy and static light 
scattering.  These were analyzed separately to allow for the monitoring of protein secondary, 
tertiary and quaternary structures, respectively, as a function of pH and temperature.  The 
collective data obtained from these diverse techniques were summarized using a three-index 
empirical phase diagram to provide an overall view of protein structure changes in response to the 
environmental conditions.  These changes were visualized via different colors and shifts in color 
change in response to pH and temperature changes.  Based on the EPD of the SipDB fusion, 
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thermal stress causes both the secondary and tertiary structures to undergo a gradual, but only 
partial loss of integrity, regardless of pH used.   However, the SipDB fusion protein recovers its 
original structural state after cooling down from thermal stress, most probably because the LDAO 
prevents aggregative events that would lead to irreversible protein-protein interactions.  
Just like the Shigella DB Fusion in LDAO, with the presence of LDAO in the SipDB 
fusion preparation appears to allow the protein to stay in a structurally resilient and rather elastic 
state that readily adapts to changes in pH and temperature.  This may be possible because LDAO 
is non-denaturing Zwitterionic surfactant with distinct positively charged N+ and negatively 
charged O- groups.  These groups may interact with charged protein residues within the fusion 
proteins to shield it from deleterious interactions [56].  Thus, LDAO may play a role beyond 
simply being a detergent.  It may also interact with certain proteins to strongly affect their surface 
features which might protect them from the negative effects of environmental stress.  The SipDB 
fusion is now being characterized for its immunogenicity using a mouse model of Salmonella 
infection.  
To summarize this work, we have successfully generated a recombinant SipD-SipB 
fusion protein that is a strong Salmonella vaccine candidate that may lead to broad protection 
against infectin by multiple Salmonella serovars.  This pre-formulation study introduces the 
detergent LDAO as a vaccine component that causes the protein to become more elastic with 
regard to its structural features and more resilient to its environment.  Most important, LDAO 
prevents aggregation of the SipDB fusion which is an important property when considering the 
need for a stable vaccine that is not adversely affected during long term storage and shipping 
[60,61]. 
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CHAPTER V 
 
BIOPHYSICAL CHARACTERIZATION OF THE TYPE III SECRETION TIP PROTEINS 
AND TRANSLOCATOR PROTEINS ALONE AND ATTACHED TO BACTERIUM-LIKE 
PARTICLES AS POTENTIAL VACCINE CANDIDATES AGAINST Shigella, Salmonella 
AND Yersinia 
 
Introduction 
Shigella and Salmonella (discussed in chapters III and IV) have been listed as Category B 
agents of bioterrorism by CDC. Category B includes agents that are easily spread through 
contaminated water or food. As previously addressed, Shigella can cause severe gastrointestinal 
illness that includes bloody diarrhea, cramping and fever. Salmonella is an important cause of 
gastroenteritis with a broad host range and more than 2500 serovars, many of which are 
responsible for human disease. Both of these organisms have the potential to become weaponized 
pathogens due to specific characteristics including low infective dose (Shigella), high morbidity 
rates [83], ease of transmission [84], increasing incidence of antibiotic resistance, and the absence 
of effective vaccines.  In addition to these two pathogens, Yersinia enterocolitica is a category B 
agent capable of causing severe gastroenteritis. Although the overall incidence of Yersinia 
infections is lower than for Shigella and Salmonella, at one time it was the most common agent of 
diarrheal disease among African-American children [85].  
Yersinia enterocolitica is the causative agent of a broad range of gastrointestinal 
syndromes, from self-limited enteritis to life-threatening systemic infection [86]. It’s also an 
important cause of seasonal bacterial gastroenteritis among young children in urban communities 
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in the southeast United States where the infection rate is only lower than that of Salmonella spp. 
in infants under 12 months of age [87]. Y. enterocolitica enters the host via oral route and crosses 
the intestinal epithelial barrier through M cells [88]. Just like Shigella and Salmonella, Yersinia 
uses a type III secretion system (T3SS) to form a translocon pore in host cell membranes for 
delivering effector proteins into the cytoplasm of host cells which causes the blockage of 
phagocytosis by macrophages and results in macrophage death [52,89,90]. It is worth noting that 
the T3SS of Y. enterocolitica is identical to that of its close relative Yersinia pestis, the causative 
agent of plague which is probably the most dangerous and well known bioterror pathogens.  It is 
likely that any vaccine effective against Y. enterocolitica will be effective against all Yersinia spp. 
In addition to being potential candidates for bioterror weapons, Shigella, Salmonella and 
Yersinia enterocolitica are major public health problems that mostly affect infants and young 
children who are most vulnerable to the dehydration and growth defects associated with diarrheal 
diseases. Even without direct contact with contaminated water, children can still be infected by 
association with ill individuals via the fecal-oral route. Thus, development of vaccines against 
these pathogens is in urgent need. Vaccination is one of the most important public health tools for 
the prevention of infectious diseases, however, formulation of safe and effective vaccines for 
newborns and infants against infectious disease can be challenging.  Subunit vaccines are usually 
safe but require a suitable adjuvant and delivery system to increase the efficacy. Dr. K. Leenhouts 
at Mucosis (http://www.mucosis.com/) has developed a novel technology using modified 
Lactococcus lactis cell wall particles as a platform for antigen delivery and referred to as 
Bacterium-Like Particles (BLPs), previously designated as Gram-positive Enhancer Matrix 
(GEM) [91,92]. L. lactis is a Gram positive, non-pathogenic lactic acid bacterium that is widely 
used in the production of dairy-based food products and generally regarded as safe (GRAS) entity 
[93]. L. lactis is one of the probiotics which have been shown to be safe for children and even 
newborns [94]. The BLPs are produced from fresh L. lactis bacteria that are harvested, boiled in 
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acid, and extensively washed with PBS. The DNA, RNA, lipids and almost all of the bacterial 
proteins are removed in this harsh treatment, but the intact peptidoglycan envelope still maintains 
structural integrity. The whole production process is simple and low cost, besides the final 
product is stable at room temperature. BLPs can be administered at mucosal sites, which is more 
“friendly” to infants when compared to needle injection. In addition to these excellent features, 
BLPs possess immune-stimulation properties conveyed by the peptidoglycan nature of the 
envelope that can activate the innate immune system through TLR2-mediated signaling [95,96]. 
As a delivery system, BLPs provide a scaffold for carrying multiple subunit antigens on 
their surface. To attach antigens to the BLP surface, the antigens need to be produced as fusions 
proteins containing a peptidoglycan anchoring (PA) domain that is also derived from L. lactis. 
The recombinant antigen-PA fusion proteins can non-covalently bind to BLPs but the association 
is extremely tight [97]. Because of the nature of the platform, single or multiple antigens can be 
displayed on a single BLP surface or BLPs carrying different antigens can be mixed, thus the 
BLPs can carry a wide variety of protein antigens from different pathogens. Pneumococcal, 
malaria and influenza proteins have been displayed on BLPs and investigated for the protective 
efficacy against their corresponding infections [98,99,100]. 
Like many other Gram-negative bacteria, Shigella, Salmonella and Yersinia all possess a 
common virulence mechanism, the TT3S, which is a syringe like structure that forms an 
energized conduit for the injection of effector proteins into host cells. Located at the needle tip is 
a “tip complex” that is involved in protein secretion control [4,52]. These include IpaD, SipD and 
LcrV for Shigella, Salmonella (from Salmonella pathogenicity island 1 or SPI-1) and Yersinia, 
respectively [101,102,103]. Upon contact with a host cell membrane, these T3SS deliver the first 
translocator protein which is also located at the needle tip for the formation of the translocon pore 
which allows later passage of effector proteins into the host cell cytoplasm. These proteins are 
IpaB, SipB and YopB for Shigella, Salmonella and Yersinia, respectively. These T3SS proteins 
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are attractive targets for inclusion in a protective vaccine due to their surface exposure and their 
essential roles in virulence. IpaD and IpaB have been found to protect against Shigella infection 
using the mouse pulmonary lethal infection model when administered intranasally  with an 
appropriate adjuvant [37].  The T3SS of Shigella and Salmonella SPI-1 are closely related, 
suggesting that SipD and SipB are also potential vaccine candidates. Although a little more 
distantly related, LcrV and YopB of Yersinia enterocolitica are functional homologs and thus are 
potential vaccine candidates. More importantly, since the tip proteins and first translocator 
proteins are very highly conserved at the sequence level within a given genus, they have the 
potential to be broad spectrum vaccine candidates capable of providing serotype-independent 
protection with, for example, the expansive genus Salmonella. Thus, this study will explore 
whether these T3SS proteins can be attached to the bacterium-like particles and then formulated 
to become T3SS protein-BLPs vaccines for later testing in animal models of infection against 
multiple category B agents.  
As protein based vaccines, the major concern regarding formulation is stability in 
aqueous solution during storage and transport. Temperature and pH are the dominant factors that 
affect protein stability. The naked BLPs are stable even at room temperature, but for the BLPs 
with associated proteins, formulation becomes something to be concerned about. Therefore, a 
variety of biophysical techniques are used here to characterize the stability as a function of pH 
and temperature.  The main techniques used here are Circular Dichroism (CD), intrinsic 
fluorescence and static light scattering spectroscopies. These multiple methods give rise to rather 
large amounts of data, so the findings generated here are summarized in a three-index empirical 
phase diagram (EPD). Furthermore, to better understand the effect of binding of PA fusion 
proteins to BLPs, we compared the biophysical studies of T3SS proteins alone, fused with the PA 
domain, and the fusion after attachment to BLPs. The PA domain was added at the C terminus of 
each tip protein, but this strategy led to poor expression and stability for the translocator proteins.  
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Thus, the translocator proteins have the PA domain attached at their N termini. Furthermore, 
IpaB, SipB and YopB are hydrophobic proteins and need to be co-expressed with their specific 
chaperones IpgC, SicA and SycD, respectively.  This also applies for expression of PA-IpaB, PA-
SipB and PA-YopB. Then the chaperones were removed with the mild detergent LDAO which is 
also needed to maintain the solubility of the resulting individual translocator proteins. Thus for 
the characterization of the translocator proteins, the PA-fusions and PA-fusions associated with 
BLPs, 0.05% LDAO was present at all times. 
 
Results 
Biophysical characterization summary of IpaD, SipD and LcrV 
Biophysical characterization of the tip proteins described here has been previously 
published [104,105], however, due to improvements in the purification scheme used to prepare 
them, it was necessary to repeat some of this work to be able to accurately compare the effects of 
fusing the PA moiety to them.  Furthermore, use of the new three-index EPD allows for direct 
comparisons of properties between different proteins, which also necessitated redoing several of 
these biophysical measurements. For IpaD, SipD and LcrV the far-UV CD spectroscopy revealed 
double minima at 208 and 222 nm in their spectra regardless of pH, indicating dominant α-helical 
content in all cases (Figs. 5.1A, 5.2A and 5.3A respectively). The spectra for each protein are 
similar at pH values with relatively minor differences except for the LcrV at pH 5 which is 
dramatically altered and suggests partially unfolding at pH 5. The thermal stability of each 
protein’s secondary structure was determined by monitoring the CD signal as molar ellipticity at 
222 nm as a function of increasing temperature (Fig 5.1-5.3B respectively). An increase in signal 
indicated a loss of α-helical structure due to unfolding of the protein.  At neutral pH conditions 
(especially pH 7 and 8), all three proteins maintained strong α-helical secondary structure until 
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~50 °C and significant unfolding was observed above 75 °C. IpaD and SipD behaved quite 
similarly in that there was a slight reduction in stability at pH which became much more 
prominent at pH 4 and 3.  For LcrV there is a slight reduction in the transition of unfolding at pH 
since and a greater reduction at pH 5 and 4.  Interestingly, LcrV at pH3 appeared to retained its 
structure until 80 °C. The reason for this latter observation is unclear, but it does appear that 
secondary structure stability is maximum in neutral pH conditions where the proteins tend to be 
quite stable. 
Tip protein tertiary structure was monitored by following intrinsic fluorescence peak 
position as a function of pH and temperature (Figs. 5.1C, 5.2C and 5.3C). As with secondary 
structure, all the proteins appear to lose stability at low pH values.  For IpaD and SipD, which 
behaved similarly to each other, the initial red shift in peak position occurs somewhat earlier than 
the initial signal change at seen in CD measurements, however, both proteins show an increase in 
peak position wavelength (a red shift) as the temperature is increased, suggesting exposure of the 
buried Trp residues to the aqueous environment as the temperature increases.  At pH 5, 4 and 3, 
there is an increasing loss of thermal stability for IpaD and SipD with the greatest loss of stability 
seen at pH 3.  At these lower pH values, the noise seen in the signal at higher temperatures is 
probably due to aggregation events.   
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Figure 5.1 : Biophysical characterization of IpaD.  Far-UV Circular Dichroism (CD) spectra of 
IpaD, recorded at different pH conditions (A). Far-UV CD molar ellipticity at 222 nm monitored 
as a function of temperature from 10 to 90 ˚C (B). Intrinsic Trp fluorescence peak position 
wavelength (C) and light scattering intensity monitored at 295 nm (D) as a function of 
temperature from 10 to 85 ˚C. Error bars represent standard deviation from three different 
experiments.   Symbols: pH 3 (■), pH 4 (□), pH 5 (●), pH 6 (○), pH 7 (▲),pH 8 (∆). 
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Figure 5.2 : Biophysical characterization of SipD.  Far-UV Circular Dichroism (CD) spectra of 
SipD, recorded at different pH conditions (A). Far-UV CD molar ellipticity at 222 nm monitored 
as a function of temperature from 10 to 90 ˚C (B). Intrinsic Trp fluorescence peak position 
wavelength (C), and light scattering intensity monitored at 295 nm (D) as a function of 
temperature from 10 to 85 ˚C. Error bars represent standard deviation from three different 
experiments.  Symbols: pH 3 (■), pH 4 (□), pH 5 (●), pH 6 (○), pH 7 (▲),pH 8 (∆). 
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Figure 5.3 : Biophysical characterization of LcrV.  Far-UV Circular Dichroism (CD) spectra 
of LcrV, recorded at different pH conditions (A). Far-UV CD molar ellipticity at 222 nm 
monitored as a function of temperature from 10 to 90 ˚C (B). Intrinsic Trp fluorescence peak 
position wavelength (C) and light scattering intensity monitored at 295 nm (D) as a function of 
temperature from 10 to 85 ˚C. Error bars represent standard deviation from three different 
experiments.  Symbols: pH 3 (■), pH 4 (□), pH 5 (●), pH 6 (○), pH 7 (▲), pH 8 (∆). 
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The tertiary structure of LcrV is very stable at neutral pHs with the transition temperature 
then decreasing as the pH is lowered. Compared to IpaD and SipD, LcrV maintains its tertiary 
structure well and almost no red shift is observed before it undergoes a blue shift which is 
probably caused by aggregation and the trapping of Trp residues within the hycrophobic core of 
the resulting aggregates. It’s noteworthy that LcrV at pH 3 starts its thermal destabilization at 
around 40 °C although it maintains its secondary structure until higher temperatures. This could 
be due to initial formation of soluble aggregates that maintain secondary structure content while 
collapsing around the core Trp residues.   
Static light scattering was used to explore aggregation of IpaD, SipD and LcrV as a 
function of pH and temperature (Figs. 5.1D, 5.2D and 5.3D, respectively). Aggregation is 
probably the most difficult property to overcome in the storage of proteins in solution and it can 
occur by factors including protein unfolding, chemical degradation and by simple time-dependent 
protein-protein interactions. Based on light scattering, IpaD and SipD once again tend to behave 
similarly.  Both proteins show good stabilitiy at netural pH are fairly stable at pH 6.  A substantial 
reduction in stability as monitored by protein aggregation was observed at pH 5, 4 and 3.  At 
these more acidic pH values, the loss of signal at higher temperatures is due to the formation of 
visible precipitates that fall out of solution.  For LcrV, a similar trend is observed, but it seems to 
be a bit more exaggerated relative to what is seen for the other two tip proteins.   
The biophysical data accumulated in the above experiments set were summarized using a 
three-index EPD. In these updated versions of the EPD model of data presentation, each 
parameter (secondary structure, tertiary structure and quaternary structure/aggregation) is 
assigned a specific color which allows for determination of the factor that most greatly influences 
each protein’s overall stability and it allows for comparison of the summarized data between 
proteins.  Three predominant regions were defined for IpaD (Fig. 5.4 A). Region 1 is yellow and 
it represents IpaD’s native state over the entire pH range and under 45-55 °C. 
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Figure 5.4 : Three-index empirical phase diagrams (EPDs) for IpaD (A), SipD (B) and LcrV (C), 
representing the conformational stability of the tip proteins as a function of pH and temperature. 
The red, green and blue panels at the right define individual component indices for secondary 
structure (CD), tertiary structure (fluorescence peak position) and aggregation behavior (LS), 
respectively.  
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IpaD is most stable over this relative large range of parameters. Region 2 represents a structurally 
altered state mostly caused by the loss of protein secondary and tertiary structure and it seems to 
almost overlay with the red and green at the right in Fig. 5.4A. Region 3 is mainly an aggregated 
(denatured) state for IpaD from pH 3 to 6 and above 60°C. Overall, IpaD is most stable at lower 
temperature at all pH values examined. It takes both an acidic environment and high temperature 
to grossly perturb IpaD structure and this disruption seems to be irreversible due to aggregation.  
The EPD for SipD seems rather similar in pattern to that of IpaD (Fig. 5.4B). Region 1 
again represents the native state at all pH values with slightly better thermostability at pH 4 and 5 
relative to IpaD. Region 2 is once again an altered structural state with minimal aggregation 
caused by the thermal unfolding. Significant aggregation activity attributed to the blue color in 
region 3 at pH 4 and 5. It is worth noting that a gray color was observed at pH 3 over 40 °C due 
to partial loss of secondary and tertiary structure, but with less aggregation compared to pH 4, 5 
and 6. This is another feature that differentiates SipD from IpaD. 
For LcrV, the EPD was more complicated and divided into 5 regions (Fig. 5.4C). Like in 
the other cases, region 1 describes the native conformational state at neutral environment and up 
to ~ 75 °C. Region 2 represented a transition state or partially unfolded state that appears at high 
temperature at near neutral pH and at lower temperatures at around pH 5. It was stated above, 
LcrV behaved oddly at pH 5 with regard to secondary structure and that likely contributes to the 
split pattern seen for region 2.  Region 3 is close to region 1 with regard to overall color, but it 
may differ slightly due to there being a slight alteration in tertiary structure as appeared as a red 
shift in the fluorescence peak position (Fig. 5.4C, green color in panel at right). At pH 3 LcrV 
maintained its secondary structure well while losing some of its tertiary and quarternary structure 
pretty quickly as the temperature increased. This phenomenon is reflected on region 4 on the 
composite EPD map. Region 5 represents the completely aggregated/denatured state of LcrV. To 
summarize, IpaD and SipD EPDs demonstrate similar patterns to indicate similar behavior for 
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these two T3SS tip proteins while LcrV possesses greater stability under neutral pH conditions 
with much lower structural integrity in acidic environments.  
 
Biophysical characterization summary of IpaD-PA, SipD-PA and LcrV-PA 
Before being able to ascertain the influence that binding to BLPs has on the T3SS tip 
proteins IpaD, SipD and LcrV, the proteins had to be prepared as fusion proteins the a 
peptidoglycan anchor (PA) domain prepared from a cell wall repair enzyme from L. lactis.  It was 
thus, also important to determine the influence that fusion with the PA had on the biophysical 
properties of these tip proteins. Far-UV CD spectroscopy was used to measure the secondary 
structure content of IpaD-PA, SipD-PA and LcrV-PA (Figs. 5.5A, 5.6A and 5.7 A, respectively). 
Double minima at 208 and 222 nm were observed with the minimum at 208 nm being more 
intense than the one at 222 nm, suggesting that there was conservation of α-helical secondary 
structure within the tip proteins, however, fusion with the PA domain did appear to introduce 
more random coil into the final secondary structure content of the proteins. To monitor retention 
of α-helical structure as a function of temperature, CD spectroscopy was used and the molar 
ellipticity at 222 nm was monitored.  
For IpaD-PA, the molar ellipticity gradually decreased at each pH with increasing 
thermal stress (Fig 5.5B), suggesting partial unfolding in response to temperature, however, there 
was no major and clear cut transition as seen for IpaD alone (see Fig.  5.1B). A similar pattern 
was observed for SipD-PA except at pH 5 and 6 where a complete unfolding transition was seen 
at 75 °C (Fig. 5.6 B). This may suggest that these two proteins tend to retain secondary structure 
content well in response to elevated temperature except for SipD at pH 3 and 4.  The effect of 
fusing PA to LcrV was interesting in that insoluble aggregates formed during dialysis into CP  
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Figure 5. 5: Biophysical characterization data for IpaD-PA. Far-UV Circular Dichroism (CD) 
spectra of IpaD-PA, recorded at different pH conditions (A). Far-UV CD molar ellipticity at 222 
nm monitored as a function of temperature from 10 to 90 ˚C (B). Intrinsic Trp fluorescence peak 
position wavelength (C) and light scattering intensity monitored at 295 nm (D) as a function of 
temperature from 10 to 85 ˚C. Error bars represent standard deviation from three different 
experiments.  Symbols: pH 3 (■), pH 4 (□), pH 5 (●), pH 6 (○), pH 7 (▲),pH 8 (∆). 
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Figure 5.6 : Biophysical characterization data for SipD-PA.  Far-UV Circular Dichroism (CD) 
spectra of SipD-PA, recorded at different pH conditions (A). Far-UV CD molar ellipticity at 222 
nm monitored as a function of temperature from 10 to 90 ˚C (B). Intrinsic Trp fluorescence peak 
position wavelength (C) and light scattering intensity monitored at 295 nm (D) as a function of 
temperature from 10 to 85 ˚C. Error bars represent standard deviation from three different 
experiments.  Symbols: pH 3 (■), pH 4 (□), pH 5 (●), pH 6 (○), pH 7 (▲),pH 8 (∆). 
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Figure 5.7 : Biophysical characterization data for LcrV-PA.  Far-UV Circular Dichroism 
(CD) spectra of LcrV-PA, recorded at different pH conditions (A). Far-UV CD molar ellipticity at 
222 nm monitored as a function of temperature from 10 to 90 ˚C (B). Intrinsic Trp fluorescence 
peak position wavelength (C) and light scattering intensity monitored at 295 nm (D) as a function 
of temperature from 10 to 85 ˚C. Error bars represent standard deviation from three different 
experiments.  Symbols: pH 5 (●), pH 6 (○), pH 7 (▲), pH 8 (∆). 
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buffer at pH 3 and 4. Thus, biophysical data for LcrV-PA were only collected at pH 5 through 8 
(Fig,. 5.7B). From pH 6 to 8, only minor changes in secondary content were seen for LcrV-PA 
until ~65 °C, however, at pH 5 the LcrV-PA had reduced α-helical signal even at 10 oC and then 
completely unfolded after 70 °C.  
The tertiary structure stability of IpaD-PA and SipD-PA, as determined by fluorescence 
peak position, appears to be similar to though maybe slightly less stable than each tip protein 
without the PA addition (Fig. 5.6C). A large blue shift (to a lower wavelength) was observed at 
~45-50 °C regardless of the pH with the degree of shift being greater at pH 3 (Fig. 5.5C and 5.6C, 
respectively). The pattern once the transition started was different than for these two proteins 
alone, however, this is likely due to the state of the protein once the major portion of the tertiary 
structure is lost.  Fusion with the PA also decreases the stability of LcrV, however, instead of 
remaining steady and then undergoing a major blue shift, a unique double transition scheme was 
observed at neutral pH while a completely loss of tertiary structure was seen above 50 ˚C at pH 5 
(Fig. 5.7C).  
As before, static light scattering was used to monitor the aggregation of the tip-PA 
protein fusions (Figs. 5.5D, 5.6D and 5.7D). Minor aggregation was observed for IpaD-PA at pH 
values of 3, 7 and 8 as thermal stress was applied, however, much greater aggregation was seen at 
pH 4, 5 and 6 as the temperature was increased. The data seem to suggest greater resistance to 
aggregation at the pH extremes, but not between. SipD-PA started to aggregate at around 45 ˚C 
and showed a midpoint of transition at around 55 oC regardless of pH (Fig. 5.6D). LcrV-PA 
seems to resist aggregation induced by thermal stress at pH values from pH 6 to 8 but completely 
early on at pH 5. Further reduction in the pH resulted in LcrV precipitation even before analyses 
could be performed, as mentioned above.   
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As was done for the tip proteins alone, the biophysical data were viewed as a whole using 
empirical phase diagrams. The EPD for IpaD-PA was divided into three regions that were loosely 
similar to the regions seen for IpaD alone, but with the overall appearance that the PA domain 
reduces overall stability (Fig 5.8A). Region 1 (yellow color) depicts the native state of the fusion 
protein with minor color differences occurring at high pH due to the minor loss of secondary 
structure at lower temperatures.  Region 2 represents a transition into a mildly altered 
conformational state that results from thermal stress with minor aggregation activity. Region 3 
then represented a major loss of structural integrity that is largely characterized by aggregation.  
For SipD-PA, only two regions were defined (Fig. 5.8B) mostly depend on the thermal increase. 
Under ~55 ˚C was the native state as defined by region 1 with the most stable state being 
observed at pH 6 and 7 according to the color scheme. Region 2 was mainly a denatured state 
where loss of tertiary structure and aggregation dominated. The EPD for LcrV-PA was once 
again quite complicated and differentiated into six regions based upon the cluster analysis (Fig. 
5.8C). The native state defined by region 1 was at neutral pH under 40 ˚C. Region 2 and 3 most 
likely represent different forms of the molten globular and partially unfolded states, respectively. 
Region 4 was defined based on the decrease of secondary structure at pH 5. Region 5 and 6 were 
differentiated from each other because partial secondary structure was still maintained at in 
region 5 relative to region 6 where there is complete denaturation.  The structure trends in this 
EPD with regard to pH would appear to provide a clue as to why no data could be obtained at low 
pH with aggregation becoming the dominant factor as pH is lowered.   
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Figure 5. 8 : Three-index empirical phase diagrams (EPDs) for IpaD-PA (A), SipD-PA (B) and 
LcrV-PA (C), representing the conformational stability of the proteins as a function of pH and 
temperature. The red, green and blue panels at the right define individual component indices for 
secondary structure (CD), tertiary structure (fluorescence peak position) and aggregation behavior 
(LS), respectively  
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Biophysical characterization summary of IpaD-BLP, SipD-BLP and LcrV-BLP 
The biophysical techniques used here tend to become complicated when trying to 
characterize proteins attached to bacterium-like particles (BLPs) because the BLPs tend to 
dominate the majority of the spectroscopic signals and create a great deal of noise in the signal. 
Nevertheless, we can still obtain stability information of the tip-BLPs as a whole using these 
methods. In some cases, other difficulties arise such as the degradation that is observed when 
IpaD-BLPs and SipD-BLPs were transferred into pH 3 buffer. In these cases, no biophysical data 
were collected and such data are omitted from this study. The far-UV CD spectra at 10 ˚C for all 
the tip-BLPs showed a single minimum at ~ 225 nm (Figs. 5.9A, 5.10A and 5.11 A).  Such a 
phenomenon was previously seen in the characterization of a live, attenuated Salmonella in a 
vaccine formulation [106]. As a general trend, signals at neutral pH for the protein-BLPs are 
more intense than that at acidic pH. A decrease in CD signal intensity was observed at pH 4 to 6, 
but not at pH 7 and 8 except for SipD-BLP at pH 7 (Figs. 5.9B, 5.10B and 5.11 B). Clearly tip 
protein-BLPs prefer higher pH values to maintain their overall secondary structure integrity.  
When tertiary structure was examined, the fluorescence peak position for IpaD-BLPs 
showed a maintenance of wavelength at pH 7 and 8 in response to thermal stress while there was 
a graduate but substantial blue shift in response to increasing temperature that could be attributed 
to aggregative events at pH 4 to 6 (Fig. 5.9C). Although the pattern differed, increased stability 
for SipD-BLPs also appears to occur at pH 7 and 8 (Fig. 5.10C).  This same trend seems to occur 
for LcrV-BLPs with the neutral pH data sets also having much less noise, suggesting they are 
more stable than below pH 7 (Fig. 5.11C).   
With regard to aggregation as determined by static light scattering, similar stability trends 
were observed with LcrV showing marginal stability relative to IpaD and SipD once attached to 
the BLPs (Figs. 5.9D, 5.10D and 5.11D).  Under all of the pH conditions used, IpaD maintains a 
relatively steady level of light scattering though it begins to drop at relatively low temperatures at 
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pH 4, 7 and 8 (Fig. 5.9D).  It should be noted that in these plots of light scattering versus 
temperature, the graduate decrease that is seen is probably due to the large BLP particles falling 
out of solution.  On the other hand, while increased light scattering is probably due to 
aggregation, a rapid drop in scattering is most likely due to large aggregates rapidly settling out of 
solution. It should be noted that the contribution from small soluble proteins (even in soluble 
aggregate form) would not be expected to contribute here due to the dominant nature of the large 
BLP particles.  Thus, IpaD appears initially to be more stable to gross aggregation at all pH 
values with minor aggregation occurring at pH 5 and 6 with some aggregation pH 4. It should be 
noted that the large error bars seen from pH 4 to 6 are probably caused by the distribution of 
aggregates as larger particles begin to rapidly settle out of solution. At about 65 oC, the IpaD-
BLPs then rapidly fall out of solution indicating major aggregative events. The gradual decrease 
in light scattering at pH 7 and 8 may suggest little true aggregation is occurring here.  
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Figure 5. 9 : Biophysical characterization data for IpaD-BLPs.  Far-UV Circular Dichroism 
(CD) spectra of IpaD-BLPs, recorded at different pH conditions (A). Far-UV CD signal at 225 
nm monitored as a function of temperature from 10 to 90 ˚C (B). Intrinsic Trp fluorescence peak 
position wavelength (C) and light scattering intensity monitored at 295 nm (D) as a function of 
temperature from 10 to 85 ˚C. Error bars represent standard deviation from three different 
experiments.  Symbols: pH 4 (□), pH 5 (●), pH 6 (○), pH 7 (▲),pH 8 (∆). 
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Figure 5. 10: Biophysical characterization data for SipD-BLPs.  Far-UV Circular Dichroism 
(CD) spectra of SipD-BLPs, recorded at different pH conditions (A). Far-UV CD signal at 225 
nm monitored as a function of temperature from 10 to 90 ˚C (B). Intrinsic Trp fluorescence peak 
position wavelength (C) and light scattering intensity monitored at 295 nm (D) as a function of 
temperature from 10 to 85 ˚C. Error bars represent standard deviation from three different 
experiments.  Symbols: pH 4 (□), pH 5 (●), pH 6 (○), pH 7 (▲), pH 8 (∆). 
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Figure 5. 11: Biophysical characterization data for LcrV-BLPs.  Far-UV Circular Dichroism 
(CD) spectra of LcrV-BLPs, recorded at different pH conditions (A). Far-UV CD signal at 225 
nm monitored as a function of temperature from 10 to 90 ˚C (B). Intrinsic Trp fluorescence peak 
position wavelength (C) and light scattering intensity monitored at 295 nm (D) as a function of 
temperature from 10 to 85 ˚C. Error bars represent standard deviation from three different 
experiments.  Symbols: pH 5 (●), pH 6 (○), pH 7 (▲),pH 8 (∆). 
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In a somewhat similar manner, SipD-BLPs tend to show an early but slight decrease in 
light scattering suggesting there little aggregation in all cases. This is followed by an increase in 
light scattering at pH 5, and 6 as would occur with mild aggregation.  At pH 7 and 8, the SipD-
BLPs show a graduate and steady drop in light scattering from the start and continuing until the 
end suggesting there is little gross aggregation at these pH values (Fig. 5.10D). At pH 4 there is 
also a rather gradual decrease in light scattering suggesting perhaps less aggregation occurring 
here relative to all the other pH conditions. Interestingly, at pH 6 (and to a lesser extent at pH 5), 
the SipD-BLPs start to show a gradual increase in scattering (after the initial drop) and then they 
rapidly fall out of solution at about 70 oC (45 oC for pH 5), perhaps due to slowly accumulating 
aggregation until a complete collapse occurs as large aggregates form. As for the LcrV-BLPs, the 
light scattering continually decreases throughout the experiment for all the pH values tested but 
the aggregation appears to be greatest at pH 5 which appears to be consistent with what was 
observed for tertiary structure (Fig. 5.11D and C, respectively).  The trend for the LcrV-BLPs is 
that as acidity increases, stability decreases. 
The association of the proteins to the BLPs ended up making the EPDs more complex 
than for the proteins alone. The EPD for IpaD-BLPs was divided computationally into three 
regions (Fig. 5.12A). Region 1 is the most stable state which is limited to pH 7 and 8, regardless 
of temperature. This was largely dictated by secondary structure and aggregation status though at 
higher temperatures at pH 7, tertiary structure begins to have an influence (see panels at right). 
Region 2 is a relatively less stable with a lower CD signal and transition at 65 ˚C. Settling of the 
tip-BLPs caused by protein aggregation is largely responsible for region 3. The EPD of SipD-
BLP is divided into 4 regions with region 1 defined as the most favorable state at relatively low 
temperatures under mostly neutral pH conditions (Fig. 5.12B). Region 2 was identified as less 
stable region due to the low CD signal. Higher temperatures at pH 8 gave rise to region 3 which 
represents a structurally altered state based on the loss of tertiary structure. Finally, region 4 
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represents the settling of protein-BLP complexes out of solution due to substantial protein 
aggregation.  Meanwhile, the most stable region (region 1) for LcrV-BLPs was at pH 7 and 8 
under ~50 ˚C (Fig. 5.12C). Regions 2 and 3 represent a partially unfolded state due to loss of 
secondary structure caused by thermal stress or pH stress, respectively. Region 4 is observed at 
higher temperatures under neutral pH conditions and it corresponds to a relatively low level of 
aggregation while region 5 results from significant aggregation that leads to clumping. In general, 
the tip protein-BLP complexes prefer neutral environment and relatively low temperatures.  
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Figure 5. 12: Three-index empirical phase diagrams (EPDs) for IpaD-BLPs (A), SipD-BLPs  (B) 
and LcrV-BLPs (C), representing the conformational stability of the tip proteins attached to the 
BLPs as a function of pH and temperature. The red, green and blue panels at the right define 
individual component indices for secondary structure (CD), tertiary structure (fluorescence peak 
position) and aggregation behavior (LS), respectively. 
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Biophysical characterization summary of IpaB, SipB and YopB 
The translocator proteins IpaB, SipB and YopB need to be co-expressed with their 
chaperones which are removed with detergent LDAO (or a suitable alternative mild detergent). In 
this case, the biophysical characterization of these proteins was all conducted with the presence of 
LDAO.  For IpaB and SipB, minor chemical degradation was seen at pH 3, which became even 
more obvious for PA-IpaB and PA-SipB. Thus, to reduce the complexity and focus on the effect 
the PA domain brings to these proteins, pH 3 was eliminated from the study. In contrast, no 
degradation was seen YopB, so it was studied at pH 3 to 8.  Far-UV CD spectroscopy revealed 
double minima at 208 and 222 nm in all the translocator protein spectra, indicating dominant α-
helical content in all cases (Figs. 5.13A, 5.14A and 5.15A).  As seen in for the DB Fusion and 
SipDB fusion, the presence of LDAO lessened the destabilizing effect of low pH for the 
translocator proteins (although IpaB at pH 7 showed a relatively stronger signal than at the other 
pH values). The thermal stability of each protein’s secondary structure was determined by 
monitoring the CD signal as molar ellipticity at 222 nm as a function of increasing temperature 
(Fig 5.13, 5.14B and 5.15B). The secondary structure of IpaB at pH 4 to 6 diminished gradually 
and a transition at ~ 45-50 °C was seen at pH 7 and 8. A similar partially unfolded state was 
reached at all pH values after reaching 90 °C. An important thing to mention here is that when the 
protein was cooled down after the thermal melt, it exhibited an identical CD spectrum as before 
the melt, which indicates that the IpaB in LDAO recovered its secondary structure. The same 
pattern was shared by SipB without any relatively obvious transition.  For YopB, the secondary 
structure was dramatically lost at pH 5 and 6 with transitions at ~ 70°C and 60 °C, respectively, 
while it was partially unfolded at the other pH values.  
The protein tertiary structure was monitored by following intrinsic fluorescence peak 
position as a function of pH and temperature (Figs. 5.13C, 5.14C and 5.15C). As with secondary 
structure, IpaB maintained its tertiary structure to over ~50 °C after the initial red shift, while a  
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Figure 5.13: Biophysical characterization of IpaB with the presence of LDAO.  Far-UV 
Circular Dichroism (CD) spectra of IpaB, recorded at different pH conditions (A). Far-UV CD 
molar ellipticity at 222 nm monitored as a function of temperature from 10 to 90 ˚C (B). Intrinsic 
Trp fluorescence peak position wavelength (C) and light scattering intensity monitored at 295 nm 
(D) as a function of temperature from 10 to 85 ˚C. Error bars represent standard deviation from 
three different experiments.   Symbols:  pH 4 (□), pH 5 (●), pH 6 (○), pH 7 (▲), pH 8 (∆). 
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Figure 5.14: Biophysical characterization of SipB with the presence of LDAO.  Far-UV 
Circular Dichroism (CD) spectra of SipB, recorded at different pH conditions (A). Far-UV CD 
molar ellipticity at 222 nm monitored as a function of temperature from 10 to 90 ˚C (B). Intrinsic 
Trp fluorescence peak position wavelength (C) and light scattering intensity monitored at 295 nm 
(D) as a function of temperature from 10 to 85 ˚C. Error bars represent standard deviation from 
three different experiments.   Symbols:  pH 4 (□), pH 5 (●), pH 6 (○), pH 7 (▲), pH 8 (∆). 
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Figure 5.15: Biophysical characterization of YopB with the presence of LDAO.  Far-UV 
Circular Dichroism (CD) spectra of YopB, recorded at different pH conditions (A). Far-UV CD 
molar ellipticity at 222 nm monitored as a function of temperature from 10 to 90 ˚C (B). Intrinsic 
Trp fluorescence peak position wavelength (C) and light scattering intensity monitored at 295 nm 
(D) as a function of temperature from 10 to 85 ˚C. Error bars represent standard deviation from 
three different experiments.  Symbols: pH 3 (■), pH 4 (□), pH 5 (●), pH 6 (○), pH 7 (▲), pH 8 
(∆). 
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gradual increase in signal was observed for SipB, suggesting a gradual, probably mild change in 
tertiary structure occrs. For YopB, a similar transition was observed as seen in the CD melt 
although it was not very sharp at pH 5 and 6. Static light scattering was performed simultaneously 
with the intrinsic fluorescence to explore aggregation of IpaB, SipB and YopB as a function of 
pH and temperature (Figs. 5.13D, 5.14D and 5.15D, respectively). LDAO has been shown to 
prevent aggregation for the DB Fusion and SipDB fusion. Consistent with being a major 
component of these fusion proteins, IpaB and SipB were also found to resist to aggregation 
activity in the presence of LDAO. No significant increase in light scattering was observed for 
IpaB regardless of temperature and pH, indicating no significant aggregation behavior, however, 
the light scattering intensity did increase a small amount at higher temperatures. Although the 
signal shows small changes, the transition temperature appear to match that seen using the other 
techniques. Therefore, minor aggregation could occur though no visible aggregates were 
observed. As for the YopB, a relatively higher light scattering signal was observed compared to 
IpaB and SipB. A significant increase in scattering is seen over 60 °C at pH 5 and this is followed 
by a decrease due to settling of the resulting protein aggregates.  
The biophysical data for the translocator proteins were then viewed as a whole using the 
three-index EPD (Fig. 5.16). For IpaB, lower temperature regions at pH 7 and 8 show the most 
native-like state which is shown as region 1, which is based on the strong CD signal and 
fluorescence peak position see under these conditions. Region 2 represents the molten globular 
state of the protein which is seen in low pH environments. Minor aggregation was suggested for 
at region 3, which is probably caused by thermal stress. It’s notable that the light scattering 
increase was very limited which might indicate the formation of smaller soluble particles. The 
EPD for SipB showed similar pattern as SipDB fusion with gradual changes in color and 
definitely no aggregation regardless of pH conditions. There are thus only two regions indicated 
for SiipB. As for the YopB, interestingly the most stable region (region 1) is seen at lower pHs.  
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Figure 5.16: Three-index empirical phase diagrams (EPDs) with the presence of LDAO for IpaB 
(A), SipB (B) and YopB (C), representing the conformational stability of the translocator proteins 
as a function of pH and temperature. The red, green and blue panels at the right define individual 
component indices for secondary structure (CD), tertiary structure (fluorescence peak position) 
and aggregation behavior (LS), respectively. 
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Overall, the color pattern seen for YopB looks very different from those of IpaB and SipB, which 
most likely is caused by the light scattering data which initially decreased as the temperature 
increased. It is possible that this could be due to micelle formation from LDAO, though it was not 
seen for the other translocator proteins. The micelle particles would disperse with increasing 
temperature and the intensity would thus go down. The only exception is the region with higher 
temperature at pH 5 where actual protein aggregation causes an increase in LS signal. 
 
Biophysical characterization summary of PA-IpaB, PA-SipB and PA-YopB 
As mentioned above, it is important to determine the influence that fusion with the PA 
has on the biophysical properties of these translocator proteins before we study their binding to 
BLPs. PA placed at the C terminus of the translocator proteins led to poor expression and 
instability. Therefore, we constructed the fusions with PA at the N terminus and LDAO was 
included to maintain the solubility of the proteins after the chaperones were removed. Chemical 
degradation was observed for PA-IpaB and PA-SipB at pH 3, so this condition was deleted from 
the study. PA-YopB formed visible aggregates when dialyzed into the CP buffers at pH 3 to 5, so 
only pH 6 to 8 were included in the study for this fusion protein. Far-UV CD spectroscopy was 
used to measure the secondary structure content of PA-IpaB, PA-SipB and PA-YopB (Figs. 
5.17A, 5.18A and 5.19A, respectively). Double minima at 208 and 222 nm were observed 
suggesting that there was conservation of α-helical secondary structure within these translocator 
fusion proteins. 
To monitor retention of α-helical structure as a function of temperature, CD spectroscopy 
was used and the molar ellipticity at 222 nm was monitored (Figs. 5.17B, 5.18B and 5.19B). For 
PA-IpaB, the molar ellipticity signal gradually decreased at each pH with increasing thermal 
stress until it reached ~50 °C, suggesting gradual and partial loss of secondary structure.  At pH 
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Figure 5.17: Biophysical characterization of PA-IpaB with the presence of LDAO.  Far-UV 
Circular Dichroism (CD) spectra of PA-IpaB, recorded at different pH conditions (A). Far-UV 
CD molar ellipticity at 222 nm monitored as a function of temperature from 10 to 90 ˚C (B). 
Intrinsic Trp fluorescence peak position wavelength (C) and light scattering intensity monitored 
at 295 nm (D) as a function of temperature from 10 to 85 ˚C. Error bars represent standard 
deviation from three different experiments.  Symbols:  pH 4 (□), pH 5 (●), pH 6 (○), pH 7 (▲), 
pH 8 (∆). 
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Figure 5.18: Biophysical characterization of PA-SipB with the presence of LDAO.  Far-UV 
Circular Dichroism (CD) spectra of PA-SipB, recorded at different pH conditions (A). Far-UV 
CD molar ellipticity at 222 nm monitored as a function of temperature from 10 to 90 ˚C (B). 
Intrinsic Trp fluorescence peak position wavelength (C) and light scattering intensity monitored 
at 295 nm (D) as a function of temperature from 10 to 85 ˚C. Error bars represent standard 
deviation from three different experiments.  Symbols:  pH 4 (□), pH 5 (●), pH 6 (○), pH 7 (▲), 
pH 8 (∆). 
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Figure 5.19:Biophysical characterization of PA-YopB with the presence of LDAO.  Far-UV 
Circular Dichroism (CD) spectra of PA-YopB, recorded at different pH conditions (A). Far-UV 
CD molar ellipticity at 222 nm monitored as a function of temperature from 10 to 90 ˚C (B). 
Intrinsic Trp fluorescence peak position wavelength (C) and light scattering intensity monitored 
at 295 nm (D) as a function of temperature from 10 to 85 ˚C. Error bars represent standard 
deviation from three different experiments.  Symbols:  pH 6 (○), pH 7 (▲), pH 8 (∆). 
  
95 
 
6 to 8 there is a bit of a transition at about 50 oC and a major transition after 60 °C, which 
represents a possible substantial structural alteration. Meanwhile the secondary structure 
continued to only gradually change at pH 4 and 5. No such apparent conformational change was 
observed for IpaB alone (Fig. 5.13B).  PA-SipB shared similar pattern as PA-IpaB but with 
different pH conditions in that the protein at pH 4 and 8 resisted rapid structural changes due to 
thermal stress while unfolding was observed from pH 5 to 7 (Fig. 5.18B). As for PA-YopB, the 
molar ellipticity started decreasing at ~28 °C and underwent a second subtle transition at ~60 °C 
(seen as a leveling off of the signal change) regardless of pH.  For all three proteins, the PA 
domain dramatically affected the secondary structure and the influence of temperature on thermal 
stability.  
The tertiary structure stability of PA-translocator proteins, as determined by fluorescence 
peak position, appears to also be significantly influenced by the addition of the PA tag in 
comparison to each translocator protein alone (Fig. 5.17C, 5.18C and 5.19C). A somewhat similar 
pattern was observed for all three proteins that started with a gradual red shift followed by a blue 
shift which was mostly likely caused by protein aggregation. As temperature firstly started to 
increase, the tertiary structure start to loosen for each and as the Trp residue became exposed a 
red shift was observed for the peak position. Then, when aggregation started to occur (as 
confirmed from light scattering data in Fig. 5.17D, 5.18D and 5.19D), the Trp became buried and 
the peak position then decreased (blue shifted).  The light scattering signal went down due to the 
settling of aggregates.  When considered separately, PA-IpaB at all pH values starts to lose 
tertiary structure and aggregate between 40 and 50 oC.  PA-SipB does the same thing at about 30 
oC at pH 7 and 8 but then becomes more stable to aggregation as the pH decreases.  Then, PA-
YopB appears to be the least stable as it loses tertiary structure and aggregates starting at about 20 
oC at each pH. 
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The EPDs of PA-IpaB and PA-SipB showed similar pattern (Fig. 5.20A and B). Region 1 
represented the most native-like state at all pH values below about 40 to 50 oC. Partial unfolding 
is represented in region 2 for PA-IpaB and the related regions 2 and 3 for PA-SipB. Regions at 
neutral pH over 50 °C, however, clearly showed signs of aggregation. PA-YopB is clearly much 
less stable than the other two with a lower aggregation ignition temperature which is obvious in 
its EPD with the large amount of blue color in regions 2 and 3. The overall structural stability of 
translocator proteins are highly affected by the addition of the PA domain. Even with the 
presence of LDAO, which was shown to prevent the translocator proteins from complete 
conformational destruction and aggregation, dramatic structural changes are observed under 
various pH conditions when the PA domain is present. Among the three proteins, YopB was 
mostly influenced by the presence of the PA domain in that it started aggregating just after 20 °C.  
 
Biophysical characterization summary of IpaB-BLP, SipB-BLP and YopB-BLP 
As seen for the tip protein-BLP complexes, the BLPs tend to dominate the majority of the 
spectroscopic signals for the translocator-BLP complexes. Due to problems with either protein 
degradation or early aggregation of the PA-translocator proteins (as mentioned previously), IpaB-
BLP and SipB-BLP complexes were only characterized from pH 4 to 8 conditions while YopB-
BLP was studied from pH 6 to 8. The far-UV CD spectra at 10 ˚C for all the tip-BLPs also 
showed a single minimum at ~ 225 nm (Figs. 5.21A, 5.22A and 5.23A), with much less signal at 
pH 4 and 5 for IpaB-BLPs, and pH 4 to 6 for SipB-BLPs. As a general trend for IpaB-BLPs and 
SipB-BLPs, signals at pH 4 and 5 decrease immediately after thermal stress started to be applied 
where it is already in a completely altered state. As the pH increases, their overall secondary 
structure was maintained relatively longer (Figs. 5.21B and 5.22B) for both proteins, although it 
was much less stable compared to the proteins alone. Clear transitions were observed with sharp 
decreases seen in the signals. Further, the secondary structure appeared to be completely lost after 
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Figure 5.20: Three-index empirical phase diagrams (EPDs) with the presence of LDAO for PA-
IpaB (A), PA-SipB (B) and PA-YopB (C), representing the conformational stability of the PA-
translocator proteins as a function of pH and temperature. The red, green and blue panels at the 
right define individual component indices for secondary structure (CD), tertiary structure 
(fluorescence peak position) and aggregation behavior (LS), respectively. 
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Figure 5.21: Biophysical characterization of IpaB-BLPs with the presence of LDAO.  Far-
UV Circular Dichroism (CD) spectra of IpaB-BLPs, recorded at different pH conditions (A). Far-
UV CD molar ellipticity at 225 nm monitored as a function of temperature from 10 to 90 ˚C (B). 
Intrinsic Trp fluorescence peak position wavelength (C) and light scattering intensity monitored 
at 295 nm (D) as a function of temperature from 10 to 85 ˚C. Error bars represent standard 
deviation from three different experiments.  Symbols:  pH 4 (□), pH 5 (●), pH 6 (○), pH 7 (▲), 
pH 8 (∆). 
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Figure 5 22: Biophysical characterization of SipB-BLPs with the presence of LDAO.  Far-
UV Circular Dichroism (CD) spectra of SipB-BLPs, recorded at different pH conditions (A). Far-
UV CD molar ellipticity at 225 nm monitored as a function of temperature from 10 to 90 ˚C (B). 
Intrinsic Trp fluorescence peak position wavelength (C) and light scattering intensity monitored 
at 295 nm (D) as a function of temperature from 10 to 85 ˚C. Error bars represent standard 
deviation from three different experiments.  Symbols:  pH 4 (□), pH 5 (●), pH 6 (○), pH 7 (▲), 
pH 8 (∆). 
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Figure 5.23: Biophysical characterization of YopB-BLPs with the presence of LDAO.  Far-
UV Circular Dichroism (CD) spectra of YopB-BLPs, recorded at different pH conditions (A). 
Far-UV CD molar ellipticity at 225 nm monitored as a function of temperature from 10 to 90 ˚C 
(B). Intrinsic Trp fluorescence peak position wavelength (C) and light scattering intensity 
monitored at 295 nm (D) as a function of temperature from 10 to 85 ˚C. Error bars represent 
standard deviation from three different experiments.  Symbols:  pH 6 (○), pH 7 (▲), pH 8 (∆). 
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the melt process was done, however, the YopB-BLPs behaved very differently with the overall 
secondary structure retained throughout the process without significant changes (Fig. 5.23 B).  
The tertiary structure was examined by fluorescence peak position changes as a function 
of temperature and pH (Fig. 5.21C, 5.22C and 5.23C). For IpaB-BLPs at pH 4 and 5, peak 
position went through a gradual red shift without sharp transition just like with the CD melt. 
Clear red shifts were seen at pH 6 to 8 at round same temperature as the transition in the CD 
signal. For SipB-BLPs, an increase of peak position at ~ 40 ˚C and ~45 ˚C were observed for pH 
7 and 8 conditions, respectively. For both cases much less noise was seen at higher pH, 
suggesting they were more stable at the higher pH. Meanwhile, the tertiary structure of YopB-
BLPs seemed to maintain itself rather well.  
With regard to the aggregation state as monitored by static light scattering, the plot 
pattern was highly consistent with the CD melt. For IpaB-BLPs and SipB-BLPs, the rapid drop in 
signal was attributed to the protein rapidly aggregating and causing the BLPs to fall out of 
solution. Interestingly, a sharp drop of intensity was found for YopB-BLPs followed by a 
gradually decrease without complete aggregation observed as seen for the other two protein-BLP 
complexes. This might indicate a self-limited structural change happened at the beginning with 
the protein retained in this state as the temperature continues to increase. Overall, it is obvious 
that BLPs associated with translocator proteins prefer higher pH conditions.  
The three-index EPDs for IpaB-BLP and SipB-BLP exhibited similar pattern with only 
two regions defined respectively (Fig. 5.24A and B). Region 1 at neutral pH and lower 
temperatures represents a more native-like state as indicated by the CD, FL peak and SLS panels 
on the right. As triggered by the settling of protein-BLPs system, sharp color transitions are 
observed as stress is applied.  As before, the YopB-BLPs behave dramatically different relative to  
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Figure 5.24: Three-index empirical phase diagrams (EPDs) with the presence of LDAO for IpaB-
BLPs (A), SipB-BLPs (B) and YopB-BLPs (C), representing the conformational stability of the 
translocator proteins associated with BLPs as a function of pH and temperature. The red, green 
and blue panels at the right define individual component indices for secondary structure (CD), 
tertiary structure (fluorescence peak position) and aggregation behavior (SLS), respectively. 
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the other two. With an initial decrease in light scattering signal, the product quickly went into a 
sub-aggregation state. Meanwhile the color changes in secondary and tertiary panel came from 
the gradual yet obvious changes in the CD and peak position signals. The rather small region 1 
thus represents the most stable state and regions 2, 3 and 4 represent various aspects of partial 
structural alterations that are from the combined effects of the different secondary and tertiary 
structure states seen under different stresses. 
 
Discussion 
The tip proteins and first translocator proteins from the type III secretion systems 
(T3SSs) of S. flexneri, S. typhimurium and Y. enterocolitica have been identified as potential 
protective antigens against infection caused by their corresponding bacterial pathogens.  To 
enhance the immune response against these protein antigens, these proteins were genetically 
fused to a peptidoglycan anchor (PA) domain, which naturally binds to peptidoglycan, so they 
could be examined as part of a new vaccine delivery system. These PA fusion proteins were thus 
bound to Bacterium-like particles (BLPs) derived from L. lactis.  The work presented here is a 
stability study to lay the foundation for future formulation studies which are required in order to 
avoid vaccine failure due to chemical modification, degradation and aggregation of the antigens. 
In this study, selected biophysical techniques were used to assess the structural stability of these 
proteins alone, their respective PA fusions, and the latter associated with BLPs under the 
pharmaceutically relevant stresses of temperature and pH. The acquired data set was then 
combined to generate a three index EPD, which is an improved diagram for visual interpretation 
of protein structural changes. EPDs are extremely useful in designing excipient screens for the 
final formulation of a stable vaccine.  
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The three T3SS tip proteins studied here have been previously shown to have a dumbbell-
like structure with N-terminal and C-terminal domains supported by an anti-parallel coiled-coil 
[81,107,108], however, the shape and size of the two ends of the structure vary for each 
subfamily resulting in protein specific functions [109]. IpaD and SipD have over 25% sequence 
similarity and are composed of two independently folding domains with the N-terminal domain 
being thermal-liable, which might explain the similar pattern of their EPDs and the double 
thermal transitions observed at neutral pH [81,105]. Compared to IpaD and SipD, LcrV exhibits a 
distinct behavior under thermal and pH stress, which is not surprising because LcrV belong to a 
different subfamily of T3SS tip proteins. While IpaD and SipD stay unaffected by pH at lower 
temperatures, LcrV prefers neutral pH conditions with reduced structural integrity under acidic 
conditions. Nevertheless, all the three tip proteins maintain a native conformational state at 
neutral pH under low to moderate thermal stress.  
The translocator proteins also play important roles in the virulence of these pathogens 
and they also appear to be potential vaccine candidates. IpaB, SipB and YopB all need to be co-
expressed with their chaperones (IpgC, SicA and SycD, respectively), which are then removed 
with mild detergent which is needed to keep the translocator proteins soluble. The mild detergent 
LDAO was used here for the preparation of all three hydrophobic translocator proteins based on 
its success with IpaB [57]. Moreover, LDAO have been shown to prevent dramatic structural 
alterations and aggregation in our study of the DB Fusion and the SipDB fusion protein. As might 
thus be expected, IpaB and SipB were also found to retain many of their structural properties in 
response to thermal stress when LDAO was present. Data were not collected for IpaB and SipB at 
pH 3 because minor degradation was observed and this was also seen for PA-IpaB and PA-SipB. 
No aggregation activity was detected by light scattering during the melting process for these 
proteins. Unfortunately, LDAO didn’t counter the pH effect for YopB and significant 
conformational changes were seen for this protein, especially from pH 5 to 7.  
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For the tip proteins, the addition of the PA domain to the C-terminus had a significant 
negative impact on their resistance to thermal stress. The introduction of PA domain clearly 
changed the CD spectra for these proteins with a much stronger signal at 208 nm, thereby 
indicating the presence of more random coil as seen for the PA protein itself (Fig. 5.25A). 
Moreover, for secondary and tertiary structure, the signature double transition of IpaD and SipD 
was absent after fusing with PA, which is most likely attributed by the PA domain (Fig. 5.25B 
and C). Interestingly, the spectroscopic characteristics of LcrV-PA are less dominated by the PA 
domain, however, it is still different from the pattern of LcrV by itself. First, insoluble aggregates 
were formed during dialysis of LcrV-PA to pH 3 and 4. Moreover, LcrV-PA at pH 6, 7 and 8 was 
more sensitive to thermal stress than LcrV alone.  
For translocator proteins, the addition of PA domain to the C-terminus led to degradation 
and significant instability, probably because effects on the protein’s folding processes. Thus, the 
PA domain was genetically fused to the N-terminus of each protein and each fusion was 
successfully purified in the presence of LDAO. Unlike IpaB and SipB in LDAO, the PA domain 
is obviously affected by pH and thermal stress, especially at higher pH (Fig. 5.26). Therefore, 
PA-IpaB and PA-SipB exhibited very different characteristics than did IpaB and SipB alone. The 
structural integrity was more impacted at higher pH. The most obvious difference is that 
aggregation is observed at higher pH values for PA-IpaB and PA-SipB while no aggregation 
occurs for IpaB and SipB alone. It’s not surprising to see these changes considering the PA 
portion is contributing to the conformational alterations, however, PA-YopB seemed to be much 
more intensely affected with insoluble aggregates appearing at low temperatures at pH 3 to 5 and 
it being highly sensitive to thermal stress at pH 6 to 8.  
Due to protein degradation only five pH conditions were examined for IpaD-BLPs, SipD-
BLPs, IpaB-BLPs and SipB-BLPs. Even fewer pH conditions were examined for LcrV-BLPs and 
YopB-BLPs due to aggregation. Although the majority of the spectroscopic signal is contributed  
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Figure 5.25: Biophysical characterization data for PA domain.  Far-UV Circular Dichroism 
(CD) spectra of PA, recorded at different pH conditions (A). Far-UV CD molar ellipticity at 222 
nm monitored as a function of temperature from 10 to 90 ˚C (B). Intrinsic Trp fluorescence peak 
position wavelength (C) and light scattering intensity monitored at 295 nm (D) as a function of 
temperature from 10 to 85 ˚C. Error bars represent standard deviation from three different 
experiments.  Symbols: pH 3 (■), pH 4 (□), pH 5 (●), pH 6 (○), pH 7 (▲),pH 8 (∆). 
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Figure 5.26: Biophysical characterization data for PA domain with the presence of LDAO.  
Far-UV Circular Dichroism (CD) spectra of PA, recorded at different pH conditions (A). Far-UV 
CD molar ellipticity at 222 nm monitored as a function of temperature from 10 to 90 ˚C (B). 
Intrinsic Trp fluorescence peak position wavelength (C) and light scattering intensity monitored 
at 295 nm (D) as a function of temperature from 10 to 85 ˚C. Error bars represent standard 
deviation from three different experiments.  Symbols: pH 3 (■), pH 4 (□), pH 5 (●), pH 6 (○), pH 
7 (▲),pH 8 (∆). 
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by the BLPs, the structural changes of the associated proteins certainly influence the behavior of 
the BLPs and give rise to specific signal patterns. It’s important to notice that the BLPs give a 
very strong initial light scattering signal because of their size, however, when the associated 
protein aggregates, the signal rapidly decreases due to the settling of the BLPs out of solution. For 
the tip protein-BLPs, despite the difference pattern exhibited by EPDs, pH 7 and 8 conditions are 
most favorable in general. This also applies to the translocator-BLPs although they are less stable 
than their respective tip protein-BLPs except for YopB-BLPs which are very stable in spite of the 
relative instability of PA-YopB. It seems like the binding activity alters the structure somehow 
and decreases the impact of the PA domain on the overall fusion protein structure.  
In this study, a large amount of biophysical data was collected. In this situation, the EPD 
technique shows its advantage in that it’s easier to interpret and more convenient to compare 
different proteins’ behavior in solution, as well as different forms of the same protein (for 
example, with or without a PA domain fusion). The three-index EPDs revealed a tremendous 
amount of structural information for these T3SS proteins before and after binding to BLPs, and in 
response to pH and thermal stress. Most significantly, this study investigated the protein-specific 
stability conferred by the binding to BLPs and the ability to differentiate the different samples 
despite the fact that the BLP moiety is the major species in solution and the protein moiety is a 
more subtle, yet defining contributor to the observe spectroscopic observations. The generated 
EPDs will now be used to provide direction for designing excipient screens and in determining 
suitable conditions for vaccine storage. Excipients will need to be identified to expand the 
thermal and acidic boundaries of the EPDs for these proteins.  
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CHAPTER VI 
 
CONCLUSIONS 
 
The purpose of this work has been to characterize the conformational stability of a series 
of type three secretion system (T3SS) proteins that are candidates for creating protein-based 
subunit vaccines against Shigella, Salmonella and Yersinia infections using a novel biophysical 
analysis tool called the three-index Empirical Phase Diagram (EPD). The information obtained 
will now be used for pre-formulation studies and the creation of a final vaccine product.  
Infectious diarrhea is an important public health problem and a major cause of morbidity 
all over the world, especially in developing countries. Infants and young children under 5 years 
old are the most vulnerable to enteric infections [110]. Limited improvements in sanitation and 
medical conditions have contributed to a reduction in mortality rate, however, the disability-
adjusted life years lost caused by these diseases cannot be made up. Furthermore, even though the 
morbidity caused by infectious diarrhea is much lower in developed countries, the cost of 
hospitalizations and absences from work/school are still considerably high. Shigella, Salmonella 
and Yersinia enterocolitica are three highly virulent water and food borne pathogens that cause a 
high incidence of infectious diarrhea. Thus, the development of vaccines against these pathogens 
is urgently needed. Vaccination is one of the most important public health tools for the prevention 
of infectious diseases, however, formulation of safe and effective vaccines can be challenging
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 – especially since all of the easily developed vaccines are already on the market.  A lot of effort 
has been made on the development of live, attenuated vaccines, but while these vaccines show 
promise, they fail to convey broad protection against closely related bacterial pathogens.  In this 
study, we focused on the pre-formulation of subunit vaccines based on T3SS proteins. 
The T3SS is a common virulence factor shared by many Gram-negative bacterial 
pathogens. Within a given species the T3SS components are highly conserved and have the 
potential to convey serotype-independent protection if developed into an efficacious vaccine. 
With the discovery of Shigella T3SS protein IpaD and IpaB as protective antigens, we developed 
two strategies for vaccine development based on T3SS proteins. The first is a fusion protein 
strategy based on the observation that the combination of IpaD and IpaB give better 
immunogenicity/protection than the individual proteins. (Data not published)  We thus decided to 
make a fusion composed of both proteins, which simplifies the production and lowers the cost. 
During the generation of this vaccine candidate, we discovered that a mild detergent called 
LDAO can convey elasticity and resiliency properties to the hydrophobic proteins being 
examined here. Furthermore, LDAO is considered safe for use in humans and is less expensive 
that OPOE and cost is an important consideration when creating a vaccine for use in the 
developing world. 
Following our initial success with the DB Fusion, we used the same strategy to construct 
a SipDB fusion for Salmonella.  An alternative vaccine strategy that we tested is to bind multiple 
T3SS antigens onto Bacterium-Like Particles derived from L. lactis. This strategy is being used to 
target newborns because L. lactis is one of the probiotics which have been shown to be safe for 
children and even newborns [94]. T3SS tip proteins and translocator proteins from Shigella, 
Salmonella and Yersinia were fused with a protein anchor (PA) domain and attached to the 
surface of BLPs. The immunogenicity of these vaccine candidates is currently under investigation 
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at the Center for Vaccine Development (CVD) at the University of Maryland, School of 
Medicine. 
Based on the two strategies mentioned above, we’ve successfully constructed a series of 
vaccine candidates. For the protein based vaccines, stability is an important issue in formulation, 
storage and shipping. The chemical and structural integrity of the proteins is easy to be 
compromised by environmental stress like pH and temperature, which can jeopardize the efficacy 
of the vaccine. Thus, an approach to characterize the stability of protein products efficiently is 
born at the right moment called three-index empirical phase diagram (EPD) which is a colored 
representation of protein structural integrity and conformational stability in response to various of 
environmental stress. To generate an EPD, multiple biophysical techniques measuring the protein 
secondary, tertiary and quaternary structural changes under environmental perturbations need to 
be applied. Meaningful colors are assigned to represent the protein structural changes, which 
makes the three-index EPD a friendly and efficient visualization technique for understanding of 
the proteins’ properties under a variety of pharmaceutically relevant stresses. In chapter II, the use 
of the biophysical techniques and EPD clearly showed the different impact of detergent OPOE 
and LDAO had on DB fusion proteins, and helped us to define a better detergent for formulation. 
Furthermore, we extended the use of these techniques and generate EPDs for protein antigens 
associated with bacterium-like particles in chapter IV. Although the biophysical techniques used 
for monitoring structural changes of proteins might not be perfect suitable for antigen-BLPs 
considering the dominant signal come from BLPs, the alteration can still be monitored. 
Significant information has been obtained from the EPDs and will be of great value for further 
development like excipient screening.  
To summarize this dissertation, I focused on the biophysical characterization of T3SS 
protein-based subunit vaccine candidates against Shigella, Salmonella and Yersinia. The large 
data set obtained for each protein or protein derivative was then summarized using an improved 
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data visualization technique, the three-index EPD, which allows for easy interpretation of the 
overall structural changes that occur in a protein as a function of pH and thermal stress. Based on 
the information acquired, we learned a great deal about the conformational changes that occur in 
these recombinant proteins in response to environmental stresses and discovered the importance 
of using the proper detergent in the pre-formulation of these subunit vaccines. Further studies that 
include excipient screening can now be guided with the information generated here.  
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APPENDICES 
Appendix A:  Recipes  
Agarose gel for DNA electrophoresis  
25 ml 1X TAE  
15 µl 6 mM Ethidium bromide  
0.3 g agarose (electrophoresis grade)  
 
1X TAE (running buffer for agarose gel electrophoresis)  
4.84g Tris  
1.142ml Glacial acetic acid  
2ml 0.5 M EDTA  
Q.S. to 1 L  
 
12% SDS-PAGE Separating Gel (Sufficient for two gels)  
3.00 ml diH20  
2.50 ml 1.5 M Tris-HCl, pH 8.8  
100 µl 10% (w/v) SDS  
4.00 ml 29:1% (w/v) acrylamide:bisacrylamide  
0.15 ml 10% (w/v) ammonium persulfate (APS)  
10 µl N,N,N′,N′-Tetramethylethylenediamine (TEMED)  
 
5% SDS-PAGE Stacking Gel (Sufficient for two gels)  
2.85 ml diH2O  
1.25 ml 0.5 M Tris-HCl, pH 6.8  
50.0 µl 10% (w/v) SDS  
1.00 ml 29:1% (w/v) acrylamide:bisacrylamide  
0.2ml 10% (w/v) APS  
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15µl TEMED  
 
Maleimide-Labeling buffer:  
50 mM 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES)  
150 mM NaCl  
5 mM Tris(2-carboxyethyl)phosphine hydrochloride (TCEP)  
pH: 7.0  
 
SDS-PAGE destain  
5% (v/v) methanol  
7.5% (v/v) glacial acetic acid  
 
SDS-PAGE running buffer  
2.42g Tris  
14.41g glycine  
1.0g SDS  
Q.S. to 1 L  
 
SDS-PAGE stain  
0.1% (w/v) Coomassie Brilliant Blue R-250  
5% (v/v) methanol  
7.5% (v/v) glacial acetic acid  
 
IMAC Binding Buffer  
20 mM Tris-HCl  
500 mM NaCl  
5mM imidazole  
pH: 7.9  
 
IMAC Charge Buffer  
50 mM NiSO4 
 
IMAC Elution Buffer  
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20 mM Tris-HCl  
500 mM NaCl  
400 mM imidazole  
pH: 7.9  
 
IMAC Strip Buffer  
20 mM Tris-HCl  
500 mM NaCl  
100 mM EDTA  
pH: 7.9  
 
IMAC Wash Buffer  
20 mM Tris-HCl  
500 mM NaCl  
60 mM imidazole  
pH: 7.9  
 
Hydrophobic Interaction Chromatography (HIC) Buffer A  
20 mM NaPO4  
1M ammonium sulfate  
pH: 7.0  
 
HIC Buffer B  
20 mM NaPO4  
pH: 7.0  
 
Q Column Start Buffer. 
10 mM Tris-HCl 
10 mM NaCl  
pH: 7.5 
 
Q Column Elution Buffer. 
10 mM Tris-HCl  
1.0 M NaCl  
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pH: 7.5 
 
Phosphate-Buffered Saline (PBS)  
130 mM NaCl  
10 mM Na2HPO4  
1.5 mM K2HPO4  
3 mM KCl  
 
Citrate Phosphate buffer recipe (2L, 20mM) 
Solution 1 
0.4 M sodium phosphate dibasic 
Sodium phosphate dibasic anhydrous    56.78 
Distilled water      1000 ml 
Solution 2 
0.4M Citric acid 
Citric acid anhydrous     76.85 
Distilled water      1000 ml 
 
Desired pH 
Vol Sol’n 1 
(ml) 
Vol Sol’n 2 
(ml) 
NaCl (g) 
(I = 150mM) 
Vol Water 
(ml) 
3 40 60 15.81 1900 
4 60 40 14.82 1900 
5 70 30 14.00 1900 
6 80 20 13.33 1900 
7 90 10 12.22 1900 
8 97 3 10.88 1900 
 
125 
 
Appendix B:  Bacterial Growth Media 
  
LB Agar  
37.0 g LB agar (ready-made mix)  
Q.S. to 1 L 
 
Luria-Bertani (LB) Broth  
25.0 g LB broth (ready-made mix)  
Q.S. to 1 L  
 
Terrific broth (TB):  
To prepare 1L of TB, combine 900 ml of tryptone-yeast (Component A) with 100 ml of TB salts 
(Component B). Components A and B must be prepared and sterilized separately. If combined 
prior to autoclave sterilization, the salts will precipitate.  
Component A (tryptone-yeast):  
12 g Tryptone  
24 g Yeast extract  
4 ml Glycerol  
900 ml nanopure H2O  
Component B (TB Salts):  
Combine the following in ~600 ml of nanopure H2O:  
125.41 g K2HPO4  
23.12 g KH2PO4 
Q.S. to 1 L  
 
Auto-induction media 1L 
5 g yeast extract 
10 g tryptone 
930 mL H2O 
Autoclave 
1 mL of 1M MgSO4, 50 mL of 20X NPS solution, 20 mL of 50X 5052 solutions were added in 1 
L of the media before incubated with pre-culture. 
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20X NPS 
66 g (NH4)2SO4 
136 g KH2PO4 
142 g Na2HPO4  
900 mL H2O 
Autoclave 
 
50X 5052 
100 g α-lactose 
25 g glucose 
250 g glycerol 
900 mL H2O 
Autoclave 
Dissolving lactose can be accelerated by warming up in microwave. 
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Appendix C:  Abbreviations 
  
AI: auto-induction 
Amp: ampicillin 
AUC: analytical ultracentrifugation 
BLPs: bacterium-like particles 
BSA: bovine serum albumin 
CD: circular dichroism 
DB: fusion protein IpaD-IpaB 
DTT: dithiothreitol 
EPD: empirical phase diagram 
IL: interleukin 
Ipa: invasion plasmid antigen 
IPTG: isopropyl thio-β-D-glactoside 
kDa: kiloDaltons 
LB: Luria-Bertani broth 
LDAO: N,N-Dimethyl-n-dodecylamine N-oxide 
LPS: lipopolysaccharide 
M: molar 
Min: minute 
MW: molecular weight 
Mxi: membrane expression of invasion plasmid antigens 
OD: optical density 
OPOE: n-Octyl-oligo-oxyethylene 
PA: protein anchoring domain 
PBS: phosphate-buffered saline 
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PCR: polymerase chain reaction 
PMN: polymorphonuclear leukocytes 
SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
SipDB: fusion protein SipD-SipB 
SLS: static light scattering 
spp: species 
T3SA: type III secretion apparatus 
T3SS: type III secretion system 
TB: terrific broth 
Tris: tris-hydroxymethyl aminomethane 
UV: ultroviolet 
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